Influenza Report
 
Download pdf
 

 

 

   

²Ä¤G³¹¡G¸V¬y·P

Author(s) §@ªÌ:

Timm C. Harder and Ortrud Werner
Translator(s) ĶªÌ: ¿ú±ê¯E Chin Chi Hou
Editor (Chinese Version)
½sªÌ(¤¤¤åª©¥»):
­³§®©yMary M.Y. Waye
English version

 

 

 

 

 

²¤¶

°ª­P©R©Ê¸V¬y·P¡A§Y¥j®ÉºÙ¬°¡u¸V³¾½E¬Ì¡v(Fowl Plague)¡A¬OÃþ¦ü³z¹L³¾Ãþ(¦pÂû°¦)¤§¶¡©Ò¶Ç¼½ªº¶Ç¬V¯f¡C¦­¦b1878¦~·N¤j§Q(Perroncito 1878)¤w¥X²{¡Cªì´Á¤@ª½³Q»~¥H¬°¬O·N¤j§Q¤W©Y¨¦(upper Po valley)¤§­Û¤Ú©³¯f¯g(Lombardian disease)¡CÁöµM¦b1901¦~Centanni ©M Savonuzzi¤w§¡»{¬°¬O¥Ñ¤@ºØ¹LÂo©Ê¯f¬r©Ò¾É­P¡A¦ý³Ì«á¨ì1955¦~¤~¥ÑSchäferª¾¹D¬O¥Ñ¤@ºØ¥s¬y¦æ©Ê·P«_¥Ò¯f¬r(influenza A viruses)©Ò·P¬V¡C¨ä¹ê¡A¬y¦æ©Ê·P«_¥Ò¯f¬r(influenza A viruses)¹ï©óÄݳ¥¥Í³¾Ãþ±H¥D(¦p³¥¥Í¤ô³¾)¨Ó»¡¡A¤@¯ë¤£·|¥X²{¥ô¦ó¼x¥ü¤ÏÀ³¡A¦]¬°¦¹¯f¬r¤§¿ò¶Ç¦]¤lÄݧC­P©R«¬¡A¯à»P¨ä±H¥D¹F¦Ü¥­¿Å¦@¥Í(Webster 1992, Alexander 2000)¡C

³o¨Ç§C­P©R©Ê¸V¬y·P¯f¬r(LPAIV)±q³¥¥Í³¶³¾¨­¤W¶Ç¦Ü¨ì®a¸V³¶³¾(¦pÂû°¦¤Î¤õ³¾µ¥)¡A¦Ó³o­Ó¹Lµ{ºÙ¬°¡u¥æ¤e·P¬V¡v¡C¥Ñ©ó¤@¯ë®a¸V³¶³¾§Ü·P¬V¯à¤O¸û®z¡A¬G¥i¯à·|¥X²{¤@¨Ç»´·L¨ü·P¬V¼x¥ü¡C¯f¬r¦pªG¦b®a¸VÅ餺¸g¹L¦h¦¸¤Ï´_·P¬V«á¡A¬°¤F¾AÀ³·sºØ±H¥D¡A¯f¬r¦³¾÷·|¥X²{°ò¦]ÅܺءC¦Ó¬y¦æ©Ê·P«_¥Ò¯f¬r¤§°Æ¿ò¶Ç¦]¤lH5¤ÎH7ªºÅܲ§¡A°£¤F¾AÀ³·sºØ±H¥D¥~¡A¤]¥[³t¤F¦¨¬°°ª­P©R©Ê¸V¬y·P¯f¬r(HPAIV)¡C¨Æ¹ê¤W¡A¥Ñ§C­P©R©Ê¸V¬y·P¯f¬r(LPAIV) ¤§°Æ¿ò¶Ç¦]¤lH5¤ÎH7¦b®a¸V³¶³¾¨­¤W¡AÅܺئ¨°ª­P©R©Ê¸V¬y·P¯f¬r(HPAIV)¬OÃø¥H¹w´úªº¡C

°ª­P©R©Ê¸V¬y·P¯f¬r(HPAIV)¦b®a¸VÅ餺¡Aªí²{¬O¬ðµo©Ê¡Bµu®É¶¡¤º¤Þ°_ÄY­«¯e¯f¤Î¹ï©ó©ö¨ü·P¬VªººØÃþ¦³ªñ¥G¦Ê¤À¦Ê¦º¤`²v¡C¥Ñ©ó°ª­P©R©Ê¸V¬y·P(HPAI)·|³y¦¨®a¸V·~·¥¤j¸gÀÙ·l¥¢¡A¬G¬ã»s¦³®Ä¹ï§Ü°ª­P©R©Ê¸V¬y·P(HPAI)¤§¬Ì­]¡A¤w¦¨¬°Ã~Âå¬É©Î¥þ²y³ÌÃöª`ªº¤@­Ó°ÝÃD¡C¦AªÌ¡A°ª­P©R©Ê¸V¬y·P(HPAI)¬O¥Ñ©ó§C­P©R©Ê¸V¬y·P¯f¬r(LPAIV)ªºÅܺءA¬G¦¹¾É­P§C­P©R©Ê¸V¬y·P¯f¬r(LPAIV)·P¬Vªº°Æ¿ò¶Ç¦]¤lH5¤ÎH7¥ç¨ü¨ìÃöª` (OIE 2005)¡C©¯¦n¡A¦b1997¦~¤§«e¡A¥uÄÝ©ó¬°¨u¨£¯e¯f¡Aª½¦Ü1950¦~¶}©l¡A¥þ²y¶È¦³24©v°ª­P©R©Ê¸V¬y·P·P¬V­Ó®×¡C

³Ìªñ¡A¸V¬y·P¦A¦¸¦¨¬°¥þ²y©ÒÃöª`¡A­ì¦]¬O1997¦~¶¡¦b«n¤¤°ê¦a°Ï¥X²{°ª­P©R©Ê¸V¬y·P¯f¬r-H5N1¡A¤Î«á§ó¶Ç¦ÜªF«n¨È¤@±a¡C¥Ñ©ó·í¤¤¥X²{¯f¬r¥Ñ¸V³¾Ãþ¶Ç¦Ü­÷¨ÅÃþ(¦p¿ß¡B½Þ¤Î¤HÃþ)¡A¬G¦¹©Ò¿×¡uºõ¶¡¶Ç¬V´¬»Ù¡v(traversed interclass barriers)®Ä¥Î¡A²{¦b¤wÃø¥HªÖ©w(Perkins and Swayne 2003)¡CÁöµM¡A¸V¬y·P¤£¬O¤@¥óªÅ«e¥¼¦³ªº¨Æ¥ó(Koopmans 2004¡BHayden¤Î Croisier 2005)¡A¦ý³o´X©v¤HÃþ¨ü·P¬V­Ó®×ªº¥X²{¡Aµ´¹ï¤£¯à±Æ°£H5N1¯f¬r·|¹ï¤HÃþ¥i¯à³y¦¨ÄY­«¯e¯f¤Î­P©R«Â¯Ù(Klempner¤ÎShapiro 2004¡F Webster 2006)¡C¥t¥~¡A¤£¤Ö¬ì¾Ç®a¶}©l´M§ä½u¯Áµý©úH5N1¯f¬r¬O§_¦³¾÷·|¹ï­÷¨ÅÃþ³y¦¨­P©R«Â¯Ù¡C¤£¹L¡A¥i¥HªÖ©wH5N1¯f¬r¤w¦¨¬°¥þ²y¤HÃþ³ÌÃöª`ªº°ÝÃD(Kaye and Pringle 2005)¡C

ªí¤@. ¹L¥h¥þ¥@¬Éªº°ª­P¯f©Ê¸V¬y·PÃzµo1

¦~¥÷
°ê®a/¦a°Ï
¨ü¼vÅT®a¸V
«~ºØ
1959
Ĭ®æÄõ Âû2¸s(¤w¤½§G) A/chicken/Scotland/59 (H5N1)
1963
­^°ê ¤õÂûºØ¯b29,000°¦ A/turkey/England/63 (H7N3)
1966
¦w¤j²¤ (¥[®³¤j) ¤õÂûºØ¯b8,100°¦ A/turkey/Ontario/7732/66 (H5N9)
1976
ºû¦h§Q¨È (¿D¬w) ³JÂû25,000°¦¡A¦×Âû17,000°¦¡AÀn16,000°¦ A/chicken/Victoria/76 (H7N7)
1979
¼w°ê ¾Ö¦³600,000°¦ªº¤@¸sÂû¡AÃZ80°¦ A/chicken/Germany/79 (H7N7)
1979
­^°ê ¤õÂû°Ó·~¹A³õ3­Ó (¨S¦³¤½§G³¶³¾Á`¼Æ) A/turkey/England/199/79 (H7N7)
1983- 1985
»«¤iªk¥§¨È¦{ (¬ü°ê)* 452¸s¤¤ªº¤@¤d¤C¦Ê¸U³¶³¾¡F¤j³¡¤À¬OÂû©ÎÃZ¡A¤Ö¶qÅÂÀl¤Î¯]Âû A/chicken/Pennsylvania/1370/83 (H5N2)
1983
·Rº¸Äõ ¦×¤õÂû800°¦¦º¤`¡F´î¤Ö¤F¤õÂû8,640°¦¡AÂû28,020°¦¡AÀn270,000°¦ A/turkey/Ireland/1378/83 (H5N8)
1985
ºû¦h§Q¨È (¿D¬w) ¦×ÂûºØ¯b24,000°¦¡A³JÂû27,000°¦¡A¦×Âû69,000°¦¡A¨S©ú½T»¡©ú«~ºØªºÂû118,478°¦ A/chicken/Victoria/85 (H7N7)
1991
­^°ê ¤õÂû8,000°¦ A/turkey/England/50-92/91 (H5N1)
1992
ºû¦h§Q¨È (¿D¬w) ¦×ÂûºØ¯b12,700°¦¡AÀn5,700°¦ A/chicken/Victoria/1/92 (H7N3)
1994
©ø¤hÄõ (¿D¬w) ³JÂû22,000°¦ A/chicken/Queensland/667-6/94 (H7N3)
1994-1995
¾¥¦è­ô* ³¶³¾Á`¼Æ¤£¸Ô¡A´î¤Ö¤F®a¸V¼Æ¥Øªº°Ó·~Âû¸s360­Ó A/chicken/Puebla/8623-607/94 (H5N2)
1994
¤Ú°ò´µ©Z* ¦×Âû¤Î¦×ÂûºØ¯b¤T¦Ê¤G¤Q¸U°¦ A/chicken/Pakistan/447/95 (H7N3)
1997
­»´ä (¤¤°ê) Âû¤@¦Ê¥|¤Q¸U°¦¤Î¤ñ«eªÌ¼Æ¥Ø¤Öªº¨ä¥L¦UºØ®a¸V A/chicken/Hong Kong/220/97 (H5N1)
1997
·s«n«Âº¸¤h (¿D¬w) ¦×ÂûºØ¯b128,000°¦¡A¦×Âû33,000°¦¡A­¹¤õÂû261°¦ A/chicken/New South Wales/1651/97 (H7N4)
1997
·N¤j§Q Âû¡B¤õÂû¡B¯]Âû¡BÀn¡BÄOÄL¡BÂF¡BÃZ¡B³¥Âû¬ù6,000°¦ A/chicken/Italy/330/97 (H5N2)
1999- 2000
·N¤j§Q* 413­Ó¹A³õ¡A¬ù¤@¤d¥|¦Ê¸U°¦³¶³¾ A/turkey/Italy/99 (H7N1)
2002- 2005
ªF«n¨È* ¤¤°ê¡B­»´ä¡B¦L¥§¡B¤é¥»¡B¬Z ®H¹ë¡B¦Ñ¾â¡B°¨¨Ó¦è¨È¡BÁú°ê¡B®õ°ê¡B¶V«n¡A¬ù¤@»õ¤­¤d¸U°¦³¶³¾ A/chicken/East Asia/2003-2005 (H5N1)
2002
´¼§Q   A/chicken/Chile/2002 (H7N3)
2003
²üÄõ* ²üÄõ¡G¹A³õ255­Ó¡A¤T¤d¸U°¦³¶³¾¡F¤ñ§Q®É¡G¹A³õ8­Ó¡A¤T¦Ê¸U°¦³¶³¾¡F¼w°ê¡G¹A³õ1­Ó¡A¦×Âû80,000°¦ A/chicken/Netherlands/2003 (H7N7)
2004
¥[®³¤j (¨õ¸Ö¬Ù)* ¸V¸s53­Ó¡AÂû¤@¤d¤C¦Ê¸U°¦ A/chicken/Canada-BC/ 2004 (H7N3)
2004
¬ü°ê (¼w¦{) ¦×Âû6,600°¦ A/chicken/USA-TX/2004 (H5N2)
2004
«n«D ¥­¯ÝÃþ23,700°¦¡AÂû5,000°¦ A/ostrich/S.Africa/2004 (H5N2)

1­×§ï¦Û Capua and Mutinelli, 2001
*¹ï³\¦h¹A³õ¦³­«¤j¶Ç¼½ªºÃzµo¡A¤Þ­P¤j¶q¸gÀÙ·l¥¢¡C¤j³¡¤À¨ä¾lªºÃzµo¥u¬OÃö«Y¦³¸ñ¶H¹A³õªº¦³­­©ÎµL¶Ç¼½¡C

 

¯f¬r

¬y¦æ©Ê·P«_¯f¬r¬O²yª¬©Î±øª¬ªº²É¤l¡A¥]»qþÓ¹F¦Ü¤K­Ó¸`¬qªº­t·¥³æÃì®Ö¿}®Ö»Ä(ss-RNA) °ò¦]²Õ¡C¥¦¾Ö¦³¥¿ÂH²G¯f¬r¬ì (Orthomyxoviridae family) ªº¿ò¶Ç©Ê½è¡A¨Ã®Ú¾Ú¨ä®Ö³J¥Õ¤Î°ò½è³J¥Õªº§Ü­ì®t²§¦Ó¤À¬°¥Ò¡B¤A©Î¤þ«¬¡C¸V¬y·P¯f¬r(AIV)ÄÝ©ó¥Ò«¬¡CÃö©ó¬y·P¯f¬rªºµ²ºc¤Î½Æ»s§Þ³N¡A³Ìªñ´N¦³¥X¦âªººî¦Xµû½×¥Xª© (¨Ò¦p Sidoronko and Reichl 2005)¡C

¥Ò«¬©M¤A«¬¬y·P¯f¬rªº¥D­n§Ü­ì¨M©w¦]¯À´N¬O¦å¾®¯À (haemagglutinin, H or HA)¤Î¯«¸gÓi»ÄžJ (neuraminidase, N or NA) ³o¨âºØ¬ï½¤¿}³J¥Õ¡C¥¦­Ì¯à¤Þ°_¯S©w¨È«¬¤Î§K¬Ì¤ÏÀ³¡A¦b ¦P¤@¨È«¬¤º¨ã¦³¹ý©³ªº«OÅ@§@¥Î¡A¦ý¦b¸ó¨È«¬ªº±¡ªp¤U¥u¦³³¡¤À«OÅ@§@¥Î¡C®Ú¾Ú³o¨Ç¿}³J¥Õªº§Ü­ì©Ê¡A¥Ò«¬¬y·P¯f¬r¤@¯ë»E¶°¦¨16­ÓH¨È«¬ (H1 - H16) ¤Î 9­ÓN¨È«¬ (N1 - N9)¡C³o¨Ç¶°¸s¬O¤À§O¦b¤ÀªRºØ¨t HA¤ÎNA°ò¦]ªº®Ö¥Ì»Ä¤Î¤w±À½×ªº®ò°ò»Ä§Ç¦C®ÉÃҹꪺ¡C

¹ï©ó¬y·P¯f¬rªº¤ÀÃþ¡AºD¥Îªº©R¦Wªk­n¨D¥]§t¨ä¯f¬r«¬§O¡B±J¥D (·í¥H¤HÃþ¬°°_·½®É¬Ù²¤)¡B¦a°Ï¡B§Ç¸¹¤Î¤ÀÂ÷¦~¥÷¡C¦Ü©ó¥Ò«¬¬y·P¯f¬r¡A·|¥H¬A¸¹¥[¤W¨ä¦å¾®¯À¤Î¯«¸gÓi»ÄžJªº¨È«¬¡C²{¦bÃzµoªºH5N1¨È¬w¥@¨tªº¨ä¤¤¤@­Ó¿Ë¥N«~ºØ¡A¬O¤ÀÂ÷¦Û¤¤°êªº¤@­Ó¬Ù (¼sªF) ªº¤@°¦ÃZ ¡A¬ÛÀ³¦a¡A¥¦³Q©w¦W¬°A/ÃZ/¼sªF/1/96 A/goose/Guangdong/1/96 (H5N1) (Xu 1999)¡C¦Ó¤ÀÂ÷¦Û­»´äªº²Ä¤@­Ó¤HÃþ·P¬VH5N1¨È¬w¥@¨t­Ó®×ªº (Claas 1998) «h³QÂkÃþ¬° A/HK/156/97 (H5N1)¡C

¦å¾®¯À¬O´O¦b¯f¬r¥]½¤¤W¡A¥Ñ562 - 566­Ó®ò°ò»Ä´Ý°ò²Õ¦¨ªº¿}°ò¤Æ¤Î¤Æ³J¥Õ¡C¨ä½¤¥½ ºÝªº²y§Î¥~³¡µ²ºc°ìªº²yª¬«eºÝ¡A»P¥½ºÝ±a¯«¸gÓi»Ä­l¥Íª«ªº¹è¿}²Õ¦¨ªº²Ó­M¨üÅéµ²¦X (Watowich 1994)¡C¯«¸gÓi»ÄžJ¡A§Y²Ä¤G­Ó¬ï½¤¿}³J¥Õ¥~µ²ºc°ì¡A·|¬I¥[³è²G»Ä¸ÑžJ¤ÏÀ³¤ÎÄÀ©ñ¦b¥XªÞ®É±q¨ü·P¬V²Ó­Mªí­±®·Àòªº¯f¬r¤l¥N¡C³o¥\¯àÁקK¤F¥XªÞ®Éªº¯f¬r»E¶°¡A©Î³\ÁÙ·|«P¶i¯f¬r³q¹L¥Ø¼Ð¤W¥Ö²Õ´ÂH½¤¶i¦æº}²¾¡A¤Þ­P¯f¬rªþµÛ (Matrosovich 2004a)¡C³o¨Ï¯«¸gÓi»ÄžJ¦¨¬°­È±oÃö¦íªº§Ü¯f¬r¥Ø¼Ð (Garman and Laver 2004)¡C¯f¬r«~ºØªº¹ï§Ü©Ê¿}³J¥ÕHA©MNAªº¬Û¤¬¨ó½Õ¬¡°Ê¡A¹ï¯f¬r²É¤lªº¦³®ÄªþµÛ¤ÎÄÀ©ñ¹Lµ{¡A¬O­«­nªº (Wagner 2002)¡C

¥Ò«¬¬y·P¯f¬r²É¤l¦Ü²Ó­Mªí­±³J¥Õ½èªºÁpô¥i¸g¥Ñ¦¨¼ô¤T»E¤Æªº¯f¬rHA¿}³J¥Õ¹F¦¨¡CÁpô¥i¥H¤À¼h¬°ÃѧO©ú½Tªº¥½ºÝ³è²G»ÄºØÃþ (N-acetyl- or N-glycolylneuraminic acid)¡A³s±µ¦Ü¥b¨Å¿}ªº°t¿}ÁäºØÃþ (£\2-3 or £\2-6)¡A¥H¤Î¦b²Ó­Mªí­±³è²G»Ä¹è¿}§ó²`¼h³¡¤Àªº¦¨¤À (Herrler 1995, Gambaryan 2005)¡C¤£¦P³è²G»Ä¹è¿}ªº¦h¼Ë¤Æªºªí¹F¨ü­­©ó¨Ó¦Û¤£¦P¬y·P¯f¬r±J¥Dªº²Õ´©MºØÃþ¡C¯f¬rªºHA¤ÎNA¿}³J¥Õ¡A¨âªÌ¹ï¬Y±J¥DºØªº¯S©w¨üÅéºØÃþªº¾AÀ³©Ê¡A¬O°ª®Ä²v½Æ»sªº­º­n±ø¥ó(Ito 1999, Banks 2001, Matrosovich 1999+2001, Suzuki 2000, Gambaryan 2004)¡C³o·t¥Ü¤FHA³J¥Õªº¨üÅéµ²¦X³æ¦ì¨Ì·ÓºØ¶¡·P¬Vªº­«¶ì (Gambaryan 2006)¡C¹Ï¤@Åã¥Ü¤F¦h¼Ëªº¨üÅéºØÃþªº¾÷±ñ¦¡Á`½×¡C¸V¬y·P¯f¬r´¶¹MÅã¥Ü¥X¹ï£\2-3³sµ²ªº³è²G»Ä¦³³Ì°ªªº¿Ë¦X©Ê¡A¦]¬°³o¬O¥X¦Û³Q³oºØ¯f¬rÂê©wªº³¾Ãþªº¤º¥Ö°_·½ (¸z¡AªÍ) ¤§¤W¥Ö²Õ´ªº¥D­n¨üÅéºØÃþ (Gambaryan 2005a, Kim 2005)¡C¬Û¤Ï¡A¾AÀ³¤HÃþªº¬y·P¯f¬r¡A«h­º¥ý±µªñ¦û¤F¤HÃþ®ð¹D«DÅÖ¤ò²Ó­Mµ´¤j¦h¼Æªº2-6³sµ²´Ý°ò¡C³oºØ¨üÅé³ß¦n¸ÑÄÀ¤FºØÄݫ̻٪º¤@³¡¤À¡AÁקK¸VÃþ¯f¬r¹ï¤HªºµL»Ùê¶Ç¬V (Suzuki 2000, Suzuki 2005)¡C¦ý³Ìªñ¡A¤wÃÒ¹ê¤F¤HÃþ®ðºÞ¤º¦³¤@©w¼Æ¥ØªºÅÖ¤ò²Ó­M¦P¼Ë±a¦³¸û§C±K«×¡B¹³¸VÃþ¨üÅ骺¿}ºó¦Xª« (Matrosovitch 2004b)¡A¦ÓÂû²Ó­M¥ç±a¦³§C¿@«×»P¤H¦PºØªº³è²G»Ä¨üÅé (Kim 2005)¡C³o©Î³\¯à»¡©ú¤HÃþ¹ï¨Ó¦Û¬Y¨Ç¸VÃþ«~ºØªº·P¬Vªº©è§Ü¤O¨Ã¤£¬O§¹¥þªº­ì¦] (Beare and Webster 1991)¡C½Þ¡AÁÙ¦³ÄOÄL¡A¨âªÌ¾Ö¦³¸û°ªªº±K«×ªº¨üÅéºØÃþ¡A¨Ï³o¨Ç«~ºØ¥i¥H¹ï¸VÃþ¤Î¤HÃþ±À©w²V¦X®e¾¹ (Kida 1994, Ito 1998, Scholtissek 1998, Peiris 2001, Perez 2003, Wan and Perez 2005)¡C

·í¯f¬r²É¤l¦¨¥\³s±µ¨ì¾A·íªº¨üÅé¡Aºô®æ³J¥Õ¨Ì¿à¤Î¤£¨Ì¿à¾÷¨î·|§â³o¨Ç¯f¬r²É¤l¦b¤ºÅé°Ï«Ç¤º¦b¤Æ (Rust 2004)¡C¯f¬r½¤»P¤ºÅ齤¿Ä¦X¡A¨Ï¯f¬rÁקK¤F¦b³o°Ï«Ç¤¤ªº¤À¸Ñ¡C³q¹L³B©ó¬ùpH5ªº®Ö¤ºÅ骺¯f¬r°ò½è-2 (M2) ³q¹D³J¥Õªº½è¤l¹B¿é¶¡±µ«P¶i¡A°ò½è-1 (M1) ³J¥Õ¤Î¦P·½¤T»E¤ÆHA¿}³J¥Õ½Æ¦Xª«ªº¤@³s¦êªºªÅ¶¡­«±Æ¯ÅÁp«K·|¶}©l¡Cµ²ªG¡A¨C­ÓHA³æ²Éªº°ª«×¿Ë¯×©Ê¿Ä¦Xµ²ºc°ì·|¼ÉÅS¥X¨Ó¡A´O¤J¤ºÅ齤¤¤¡A±q¦Ó¤Þ°_¯f¬r½¤¤Î·»žJÅ齤ªº¿Ä¦X (Haque 2005, Wagner 2005)¡C

¹Ï¤@. ¥Ò«¬¬y·P¯f¬r¨üÅé°¾¦n·§­n (¼Æ¾Ú°ò©ó Gambaryan 2005)

±µþÓ¦b®Ö¦ç´ß³J¥Õ (®Ö¿}®Ö³J¥Õ½Æ¦XÅé¡Aribonucleoprotein complex¡ARNP) «OÅ@¼h¤ºªº¤K­Ó¯f¬r°ò¦]²Õ®Ö¿}®Ö»Ä¤À¸` (genomic RNA segments) ·|³QÄÀ©ñ¨ì²Ó­M½è¡C¦b¨º¸Ì¡A¥¦­Ì·|³Q¶Ç°e¦Ü²Ó­M®Ö§@¯f¬r§@«H¨ÏRNAÂà¿ý©M°ò¦]²ÕRNA½Æ»s¡C³o­Ó½ÆÂøªº¹Lµ{¥Ñ¯f¬r¤Î²Ó­M¦]¤l·L§®¦a±±¨î (Whittaker 1996)¡CRNA¨Ì¿àRNA»E¦XžJ(RNA-dependent RNA polymerase¡ARdRp) ¬O¥Ñ¯f¬rPB1¡APB2¤ÎPA³J¥Õªº½Æ¦XÅé²Õ¦¨¡A¦Ó³o¶µ¤u§@¬O»Ý­n¥]³òªºRNA (RNPs)¡C¦b¯f¬r³J¥ÕªºÂàĶ¤ÎÂÃþÓ¤w½Æ»sªº°ò¦]²ÕRNA®Ö¦ç´ßªº¶°¦X¤§«á¡A¤l¥N¯f¬r²É¤l±q²Ó­M½¤µoªÞ¦Ü¯f¬r¿}³J¥Õ¤§«e´O¤J¨º³B¡CÁ³±Ûª¬®Ö¦ç´ß¤Î¯f¬r¥]½¤³J¥Õ¶¡ªº±Æ¦C¬O¥Ñ§Î¦¨¯f¬r¥]½¤¤U´ßª¬µ²ºcªº¯f¬r°ò½è-1 (M1) ³J¥Õ±±¨î¡C¦b¹ý©³³\¥iªº²Ó­M¤º¡A­Y²z·Qªº°ò¦]¸s¦s¦b¡A¯f¬rÁc´Þ¬O¤@­Ó§Ö³t (¤Ö©ó¤Q¤p®É) ¤Î°ª®Ä²vªº¨BÆJ (Rott 1979, Neumann 2004)¡C

±q¬y·P¯f¬rªºÆ[¹î¥i¥H¬Ý¥X¡A¥Ñ©ó¯f¬rRdRpªº¿ù°t¬¡©Ê¡A¨C­Ó®Ö¥Ì»Ä¨C¦¸½Æ»s¶g´Á·|²£¥Í¦h©ó5x10-5­Ó®Ö¥Ì»ÄÂàÅܪº°ªÅܲ§²v¡A¥H­P¨C­Ó°ò¦]²Õ¨C¦¸½Æ»s³£¦³®t¤£¦h±µªñ¤@­Ó®Ö¥Ì»ÄÂàÅÜ (Drake 1993)¡C°²¨Ï¿ï¾Ü©ÊÀ£¤O (¦p¤¤©M§ÜÅé¡A¦¸²z·Q¨üÅéµ²¦X¡A©Î¤Æ¾Ç§Ü¯f¬rÃÄ) ¦b¯f¬r½Æ»s®É¥H±J¥D©Î±Ú¸sµ{«×§@¥Î¤¤¡A¦³¬ÛÀ³¿ï¾Ü©ÊÀu¶Õªº¬ðÅÜÅé (¦p°kÁפ¤©M¡A­«¶ì¨üÅéµ²¦X³æ¦ì) ¥i¯à·|³Q¥X¦Ó¦¨¬°¨º±J¥D©Î±Ú¸s¯f¬r·ÇºØªºÅã©ÊÅÜÅé¡C¦p½¤¿}³J¥ÕHA¤ÎNAªº§Ü­ì¨M©w¦]¯À¨ü§K¬Ì¤O¾÷¨î¼vÅT¡A¨º (³v¨Bªº) ¹Lµ{Âk§@§Ü­ìÄƲ¾ (Fergusson 2003)¡C

¬Û¤Ï¡A§Ü­ì¦ì²¾¬O«ü§Ü­ì¨M©w¦]¯Àªº¬ðµM¤Î§¹¥þ§ïÅÜ¡A¦p¦b¦P¤@½Æ»s¶g´Á¤¤H©M/©ÎNªº¨È«¬ÂàÅÜ¡C³oµo¥Í©ó¦P®É³Q¨âºØ©Î¥H¤W¤£¦P¨È«¬ªº¥Ò«¬¬y·P¯f¬r·P¬Vªº²Ó­M¡C¦]¬°¤w½Æ»s°ò¦]²Õ¤À¸`¨ìµoªÞ¤¤ªº¯f¬r¤l¥Nªº¤À§G»P¨C¤À¸`ªº¨È«¬°_·½¬O¿W¥ßµo¥Íªº¡A¥i¯à·|¥X²{±a¦³¤£¦P¯f¬r¿Ë¥N¿ò¶Ç«H®§ªº¦³½Æ»s¯à¤Oªº¤l¥N (©Ò¿×ªº­«°tÅé) (Webster andHulse 2004, WHO 2005)¡CÁöµM1957¦~¤Î1968¦~¬y¦æªº¤HÃþ¬y·P¯f¬r (¤À§O¬OH2N2©MH3N2) ÅãµM¬O¥Ñ¤HÃþ¤Î¸VÃþ¯f¬rªº­«°t©Î­«·s±Æ¦C²Õ¦X¦Ó²£¥Í¡A1918¦~¤Þ°_¡u¦è¯Z¤ú¬y·P¡vªº¬y·P¯f¬r¦ü¥G¬O§¹¥þ­l¥Í¦Û¸VÃþ (Belshe 2005)¡C

 

¤ÑµM±J¥D

³¥¥Í¤ô³¾¡A¤×¨ä¬O¶­§Î¥Ø (Àn¡BÃZ) ¤Î§Î¥Ø(®üÅáBÀس¾) ªº¦¨­û¡A¬O¥Ò«¬¬y·P¯f¬r¥þ³¡¨È«¬ºØÃþªº±aµßªÌ¡A©Ò¥H³Ì¦³¥i¯àºc¦¨¥þ³¡¥Ò«¬¬y·P¯f¬rªº¤ÑµMÀx®w (Webster 1992, Fouchier 2003, Krauss 2004, Widjaja 2004)¡C¬Û«H©Ò¦³³¾Ãþ«~ºØ³£¬O©ö¨ü¼vÅT¡A¦ý¤@¨Ç®a¸V¡A¦pÂû¡B¤õÂû¡B¯]Âû¡BÄOÄL¡B³¥Âû¡A¬O¤wª¾¯S§OÃø©è¿m¹ï·P¬Vªº«á¿ò¯gªº¡C

¥Ò«¬¬y·P¯f¬r´¶¹M¤£·|¨Ï¤ÑµM±J¥D¥Í¯f¡C¤Ï¦Ó¡A¥¦­Ì·|«O«ù¶i¤ÆÀR¤î¡A³Q¶H¼x¯Â²b¶i¤Æªº§C(N/S¤ñ¨Ò)«D¦Pª«²§¦W/¦Pª«²§¦WÅܲ§¤ñ¨Ò§@¤À¤l«H¸¹³qª¾ (Gorman 1992, Taubenberger 2005)¡C±J¥D»P¯f¬r¦ü¥G¥H¤@­Ó·¥²Ó½o¥­¿Åªº¬Û¤¬§Ô­@ª¬ºA¦s¦b¡A³o¬O±qÁ{§É¥H¯Ê¥F¯e¯f¤Î°ª®Ä²v¯f¬r½Æ»s±o¥HÃÒ©ú¡CÁT«K¥i¥H±Æ¥X¤j¶qªº¯f¬r,·í¤¤¨C§J§t¬Û·í©ó108.7 ¸V­F¥b¼Æ·P¬V¶q (EID50) (Webster 1978)¡C·í³o¨Ç¯f¯f¶Ç¼½¨ì°ª«×Ãø©è¿mªº®a¸V«~ºØ¡A³q±`·|²£¥Í»´·Lªº¯f¼x¡A­Y¦³ªº¸Ü¡C³o¤@ªí«¬ªº¯f¬r¬OÄÝ©ó§C­P¯f«¬ (LPAIV)¡A¦Ó¤@¯ë¥u·|¹ï¥Í³J¸V¯bªº³J²£¶q¾É­P»´·L¤Îµu¼È¤U­°©Î´î¤Ö¥¿³Q¾iªÎªº¸V¯bªº­«¶q¼Wªø (Capua and Mutinelli 2001)¡CµM¦Ó¡A¦b¶Ç¬V¤Î¾AÀ³·s®a¸V±J¥D«á¡AH5¤ÎH7ªº¨È«¬«~ºØ¦³¼ç¦bªº¥i¯à·|¬ðÅܦ¨°ª­P¯f©ÊÃþ«¬¡C¦b³¥¥Í³¶³¾¤¤±q¨SÆ[¹î±o¨ìH5¡BH7©Î¨ä¥L¨È«¬ªº°ª­P¯f«¬°_·½ (Webster 1998)¡C©Ò¥H¡A¦¹°ª­P¯f«¬§ó¥i³Qµø¬°¤H¬°ªº¡A¥u·|¬O¤HÃþ¹ï¦ÛµM¥­¿Åªº¨t²Î§@¥X¤z¹wªºµ²ªG¡C

·í°ª­P¯f«¬¯f¬rªºªí«¬¦b®a¸V¤¤¥X²{¡A¥¦­Ì¥i¥H¥Ñ®a¸V¤ô¥­¶Ç¼½¦^³¥¥Í³¶³¾¸s¡C³¥¥Í³¶³¾¹ï°ª­P¯f«¬¯f¬r¤Þ°_ªº¯e¯fªºÃø©è¿m©Ê¡A¨Ì·Ó¨äºØÃþ¡B¦~ÄÖ¡B¯f¬rºØ¨Ó¬Ý¡AÅܤƫD±`¤j¡C°ª­P¯f«¬¯f¬r¥u¬O­Ó§O¦a·¸¥X¨ì³¥¥Í³¶³¾¸s¡A¦Ó¥B¥u­­©ó·í¦a (1961¦~«n«D¿PÅìÛÄ~¦º¥h¥uÄÝ­Ó§O¨Ò¤l [Becker 1966])¡A¦]¦¹¨S¦³µ¹³¥¥Í³¶³¾­q¬°¦³¬y¦æ¯f¾Çªº­«­n§@¥Î¨Ó¶Ç¼½°ª­P¯f«¬¯f¬r¡Aª½¦Ü¨È¬w¥@¨tªºH5N1°ª­P¯f«¬¯f¬rªº¥X²{ (Swayne and Suarez 2000)¡C¦Û±q2005¦~¦­´Á¡A¦b¤¤°ê¦è¥_³¡ªº«C®ü´ò¦ÛµM«OÅ@°Ïªº³¥¥Í¤ô³¾¤¤¡AÆ[¹î¥XH5N1ªº¬ÛÃö°ª­P¯f«¬¨È¬w¥@¨tªº¤jÃzµo (Chen 2005, Liu 2005)¡A³o±¡ªp¥i¯à¤w¦b®Ú¥»¦a§ïÅÜ¡C¦]¦¹¡A¦b2005¦~¥i¥Hµo²{³o¯f¬r¦V¼Ú¬wªº¶i¤@¨B¶Ç¼½ (OIE 2005)¡C³o¤@¹Lµ{ªº¸Ô±¡¤Îµ²ªG¦p¤U:

¹Ï¤G. ¸V¬y·Pµo¯f¤Î¬y¦æ¯f¾ÇºK­n

LPAIV ¢w §C­P¯f©Ê¸V¬y·P¯f¬r; HPAIV ¢w °ª­P¯f©Ê¸V¬y·P¯f¬r; HA ¢w ¦å¾®¯À³J¥Õ; ¦³½bÀYªºµê½uªí¥ÜºØÄÝ«Ì»Ù

 

°ª­P¯f©Ê¬y·Pªºµo¯f

¥Ò«¬¬y·P¯f¬rªº´¶¹M¯S©Ê ¢w ­P¯f©Ê¡A¬O¤@­Ó¦h°ò¦]©Êª¬¡A¦Ó¥B¦b²³¦h°ò¦]¸s¤§¤¤¡A¤j¶q¦a¨Ì¾a·|¼vÅT±J¥D¤Î²Õ´ÁͦV©Ê¡B½Æ»s®Ä¤O¤Î§K¬Ì°kÁ×¾÷¨îªº²z·Q°ò¦]¸sµ¥¦]¯À¡C¥t¥~¸g¹LºØ¶¡¶Ç¬V¡A¯S©wªº±J¥D¤Îª«ºØ¦]¯À«P¦¨·P¬V¡A±N¾É­P¤@¶}©l¤£¥i¹w®Æªºµ²ªG¡C¸V¬y·P¯f¬rªº°ª­P¯f«¬¥u­­©l©ó¥Ò«¬¬y·PH5¤ÎH7¨È«¬¡CµM¦Ó¡A¥u¦³¤Ö¼ÆH5¤ÎH7¨È«¬§e²{¥X°ª«×­P¯fªº¥Íª««¬ (Swayne and Suarez 2000)¡C³q±`¡AH5¤ÎH7¯f¬r¦b¤ÑµM±J¥D¤º¦w©w¦a«O«ù§C­P¯f«¬¡C¯f¬r¯à±q³oÀx®w¤¤³z¹L¤£¦P³~®| (¨£¤U) ¶Ç¤J®a¸V¸s¤¤¡C¯f¬r¦b©ö¨ü¼vÅTªº®a¸V±Ú¸s¡AªuþÓ¥iÅܤΤ£©ú½Tªº´`Àô®É´Á¡A¤j·§ÁÙ¦³¾AÀ³¡A¯à°÷¸õÅD¬ðÅܦ¨°ª­P¯f«¬ (Rohm 1995)¡C

®Ö¥Ì»Ä§Ç¦C´ú©wÃÒ©ú¤F¤j³¡¤À°ª­P¯f©Ê¸V¬y·P¯f¬rªºHA°ò¦]¦³¦@¦Pªº¯S¼x¡A¯à°÷§@¬°®a¸Vªº¬r©Ê¼Ð°O (Webster 1992, Senne 1996, Perdue 1997, Steinhauer 1999, Perdue and Suarez 2000)¡C

¬°¤F±o¨ì·P¬V¤O¡A¥Ò«¬¬y·P¯f¬r²É¤l»Ý­n±N¥ÑHA0¥ýÅXÅé¸g¤º³J¥Õ³B²z¦¨¤G²¸¤ÆÁäHA1,2¤G»Eª«ªºHA³J¥Õ²V¦X (Chen 1998)¡CHA2¨È³æ¦ì·s³yªº®ò°òºÝ¥]þÓ¤@­Ó¥Ñ¿Ë¯×©Êµ²ºc°ì²Õ¦¨ªº¿Ä¦X(Skehel 2001)¡C¯f¬r½¤¤Î·»¤ÎÅ齤ªº¿Ä¦X¹Lµ{·¥»Ý­n³o­Óµ²ºc°ì¡A¦]¬°¥¦·|¤Þµo¯f¬r°ò¦]²Õ¤À¸`«I¤J±J¥D²Ó­M½èªº¹Lµ{¡C§C­P¯f«¬¯f¬rªºHA°Å¤Á¦ìÂI¥Ñ¦ì¸m -1/-4 (H5) ¤Î -1/-3 (H7) ªº¨â­Ó®ò°ò»Ä²Õ¦¨ (Wood 1993)¡C³o¨Ç¦ìÂI¥i¥HÅý¯S§O³ßÅw¦b©I§l¤Î¸z­G¤W¥Öªí­±ªí¹Fªº¯S©w²Õ´¯Ø³J¥Õ¯ëªº³J¥Õ¯ë¶i¤J¡C¦]¦¹¡A³Ì¤Ö¬O¦b¤ÑµM±J¥D¤º¡A§C­P¯f©Ê¸V¬y·P¯f¬rªº°ª®Ä²v½Æ»s¬Û«H¬O¤j¤j¦a§½­­©ó³o¨Ç¦ìÂI¡C¬Û¤Ï¡A°ª­P¯f©Ê¸V¬y·P¯f¬rªº°Å¤Á¦ìÂI¤@¯ë§t¦³ÃB¥~ªºÆP©Ê®ò°ò»Ä (ºë®ò»Ä©M/©Î¿à®ò»Ä)¡A¨Ï±o¦ìÂI¯à³B²z¹ï-R-X-K/R-R-³Ì¤p¦@¦³§Ç¦C¯S©wªºsubtilysin¯ë¤º³J¥ÕžJ(Horimoto 1994, Rott 1995)¡C³oÃþ³J¥ÕžJ (¦p¥±ªL³J¥ÕžJ¡A³J¥ÕžJÂà¤ÆžJ) ¬¡ÅD©ó®t¤£¦h¹M§G¨­Å骺¨C­Ó²Õ´¡C¦]¦¹¡A±a¦³³o¨Ç¬ðÅܪº¯f¬r¾Ö¦³¦³¨t²Î¦a¤£¨ü­­¨î¦a½Æ»sªºÀu¶Õ¡C³o¹Lµ{¤w¦b³o»â°ìªº¼Æ­Ó³õ¦X¦³ÃÒ¾ÚÃÒ©ú¡C¨Ò¦p¦b·N¤j§Q¡A¥H«e¦b¤õÂû¤ÎÂû°¦¸s¤¤¶Ç¼½¤F¼Æ¤ëªº§C­P¯f©Ê¸V¬y·PH7N1¯f¬r¡A¦b1999¦~12¤ë¡A°ª­P¯f©ÊH7N1¸V¬y·P¯f¬r¥X²{¤Î¤Þ°_¤F·´·À©Êªº¯e¯f¡A¦Ó¥u¯à±q³o¯f¬rªº¦hÆP°Å¤Á¦ìÂI§â¥¦¤Î¨ä¥ýÅXªÌ¤À¿ë¥X¨Ó (Capua 2000)¡C

¤w¦³°²»¡ªí¥ÜH5¤ÎH7¨È«¬ªºHA°ò¦]¥]¦³¤@¿W¯SªºRNA¤G¯Åµ²ºc¡A¥H¦b¸Ñ½X§@HA³J¥Õªº¤º³J¥Õ°Å¤Á¦ìÂIªº¦háIËï§Ç¦C½d³ò¤§¯f¬r»E¦XžJ³æ¦ìªº¦A½Æ»s¾÷¨î¡A¦³§U©ó´¡¤J¬ðÅÜ (±K½X½Æ»s) (Garcia 1996, Perdue 1997)¡C³o¾÷¨î¡A¤j·§ÁÙ¦³¨ä¥L¦p®Ö¥Ì»Ä´À¥N©Î¤ù¬q¶¡­«²Õªº¾÷¨î (Suarez 2004, Pasick 2005)¡A©Î·|¤Þ­PÆP©Ê®ò°ò»Ä´Ý°òªºµ²¦X¡C«áªÌ¤w¸g¥Ñ¹êÅç¡AªuþÓ©w¦ì¬ðÅܧΦ¨­«½Æ³q¹LÅ餺¥~¡A¨Ï§C­P¯f©Ê¸V¬y·P¯f¬r¥ýÅXªÌ²£¥Í°ª­P¯f©Ê¸V¬y·P¯f¬r¨ÓÃÒ©ú (Li 1990, Walker and Kawaoka 1993, Horimoto and Kawaoka 1995, Ito 2001)¡C¬Û¤Ï¦a¡A¥Î¤Ï¦V¿ò¶Ç¾Ç°£¥h¦hÆP°Å¤Á¦ìÂI·|´î¤Ö°ª­P¯f©Ê¸V¬y·Pªí«¬ (Tian 2005)¡C

¥i¬O¡A¯f¬rºØ:¸Ñ½X§@HA°Å¤Á¦ìÂIªº®Ö¥Ì»Ä§Ç¦C»P¹w´Áªºªí«¬/­P¯f«¬¤£¦P,¥Ñ¤ù¬q¶¡­«²Õ§Î¦¨ªº´¼§Q¤HH7N3°ª­P¯f©Ê¸V¬y·P¯f¬r¥u¦b¦ì¸m-1, -4¤Î-6ªí²{ÆP©Ê®ò°ò»Ä (Suarez 2004)¡CH5¥@¨t¦s¦bþÓ¥i¥H¤ñ¸ûªº¨Ò¤l (Kawaoka 1984)¡C¬Û¤Ï¡A¬ü°ê¼w¦{¤@H5N2¹jÂ÷ª«Ãҹꤺ§t°ª­P¯f©Ê¸V¬y·P¯f¬r°Å¤Á¦ìÂIªº¤@­P§Ç¦C¡A¦ý³QÁ{§É¤ÀÃþ¬°§C­P¯f©Ê¸V¬y·P (Lee 2005)¡C³o¨Ç¸ê®Æ¦A¦¸±j½Õ¸V¬y·P¯f¬r­P¯f©Êªº¦h°ò¦]¤Î¿ùºî½ÆÂøªº©Ê½è¡C

©¯¹B¦a¡A¦b¥Ð³¥°_·½ªº°ª­P¯f©Ê¸V¬y·Pªí«¬¦ü¥G¨u¨£¡C¦b¹L¥h¤­¤Q¦~¡A¥Ñ°ª­P¯f©Ê¸V¬y·P¯f¬r¤Þµoªº°ª­P¯f©Ê¸V¬y·PÃzµo(­º¦¸ªº)¥u¦³24©v¡A«Ü¥i¯à­«·s¥X²{¦b¥Ð³¥¤W¡C³o¤w¦b¥þ²y¼sªx³ø¾É¡C (ªí¤@)

¦¹¥~¡A¤wÃҹ갪­P¯f©Ê¸V¬y·P¯f¬r¯à°÷·P¬V­÷¨ÅÃþ°Êª«¡A¯S§O¬O¤HÃþ¡C³o¤w³Q±Mªù¦a¹ïH5N1¨È¬w¥@¨t¤w¸gÆ[¹î¨ì(WHO 2006)¡C°ª­P¯f©Ê¸V¬y·P¯f¬rH5N1¹ï­÷¨ÅÃþ°Êª«ªº¨Ì¿à±J¥D­P¯f©Ê¤w¦b¼Æ­ÓºØÄݼҫ¬¤¤¬ã¨s: ¦Ñ¹« (Lu 1999, Li 2005a) ¡A ³·¶I (Zitzow 2002, Govorkova 2005) ¡A cynomolgousµU¤l (Rimmelzwaan 2001) ©M½Þ (Choi 2005)¡C·P¬Vªºµ²ªG¨ú¨M©ó¯f¬rºØÃþ¤Î±J¥DºØÄÝ¡C³·¶I¦ü¥G¸û¦Ñ¹«¯à¹ï¤Hªº­P¯f©Ê¤Ï¬M¸û¦n(Maines 2005)¡C

¤@¨Ç¬Û«H¬O²o¯Aµo¯fªº¿ò¶Ç¼Ð°O§¤¸¨©óH5N1ªºZ°ò¦]«¬ªº¤£¦P¤À¸` (ªí¤G)¡C¨ä¤¤¡A³z¹LNS-1°ò¦]²£ª«¤z¹w±J¥D¥ý¤Ñ§K¬Ì¾÷¨îªº¾÷¨î¡A¦p¤zÂZ¯À¨t²Î¡A¨ü¨ì©úÅ㪺Ãöª`¡C¹êÅç¤W¡A ¤w¥Î¤Ï¦V¿ò¶Ç¾ÇÃÒ©ú¤@¨ÇH5N1«~ºØ¦b¦ì¸m92¤W±a¦³¨¦®ò»ÄªºªºNS-1³J¥Õ¯à°÷ªý¤î¤zÂZ¯À¤Î¸~½FÃa¦º¦]¤l£\ªº§Ü¯f¬r§@¥Îµo¥Í¡A³Ì²×¤Þ­P¨ü·P¬V±J¥D¤ºªº½Æ»s¼W±j¤Î´î¤Ö±q±J¥Dªº²M°£(Seo 2002+2004)¡C¥t¥~¡ANS-1±±¨îªº²Ó­M¦]¤lºôµ¸¤Àµõ²£¥Íªº§K¬Ì±±¨î¶Ë®`©Î³\¯à»¡©ú³¡¤ÀªÍ³¡·l®` (Cheung 2002, Lipatov 2005)¡CµM¦Ó¡A¨S¦³¤@­Ó¬ðÅÜ (ªí¤G) ¯à¿W¥ß¦a¶H¼x­÷¨ÅÃþ°Êª«¤ºªº­P¯f©Êªº¯u¥¿­º­n±ø¥ó (Lipatov 2003)¡C¦]¦¹¡A¦b­÷¨ÅÃþ°Êª«¡A²z·Q°ò¦]¸s¬Ý¨Ó¸û¤jµ{«×¤W¥H¨Ì¿à±J¥Dªº¤è¦¡­¢¨Ï¥X­P¯f«¬¯S©Ê (Lipatov 2004)¡C

ªí¤G. ÃÒ¹ê»P°ª­P¯f©Ê¨È¬w¥@¨tH5N1¯f¬r´£°ª­÷¨ÅÃþ°Êª«­P¯f©Ê¦³Ãöªº°ò¦]¦ìÂI·§­n

°ò¦]¡A ³J¥Õ
¬ðÅÜ
¼vÅT
°Ñ¦Ò
HA ¦hÆP°Å¤Á¦ìÂI ¨t²Î©Ê´²¼½¤Î½Æ»sÀu¶Õ (®a¸V¡A­÷¨ÅÃþ) ²³¦h
NA ²ô³¡ªº19-25­Ó ®ò°ò»Ä§R°£ ¾AÀ³¦bÂû¤Î¤õÂû¤ºªº¥Íªø(?) Matrosovich 1999, Giannecchini 2006
PB2

627K
701N

¦b¹«¤º¼W¥[¨t²Î©Ê½Æ»s
¦b¹«¤º´£°ª­P¯f©Ê
Hatta 2001, Shinya 2004
Li 2005
PB-1 13P, 678N ´£°ª»E¦XžJ¬¡°Ê¡F¦³§U©ó¦­´ÁºØÄݯS²§¾AÀ³¹Lµ{? Gabriel 2005
NP 319K
NS-1 92E ¦b½Þ¤º«P¶iÁ׶}¤Ñ¥Íªº§K¬Ì¤ÏÀ³¡A´î¤Ö½Þ¤ºªº¯f¬r²M°£ Seo 2004

 

Á{§Éªí²{

ºò±µ³q±`¼Æ¤Ñ (¨u¦³ªº¥i¥H¨ì21¤Ñ) ªº¼ç¥ñ´Á¡Aµø¹jÂ÷ª«¯S¼x¡B±µºØª«¾¯¶q¡Bª«ºØ¡B³¶³¾ªº¦~ÄÖ¦Ó©w¡A³¾Ãþªº¸V¬y·PÁ{§Éªí²{¬O¥iÅܪº¡A¦Ó¨ä¯f¼x¬O»á¬°¤£¿W¯Sªº (Elbers 2005)¡C¦]¦¹¡A¥u¾aÁ{§Éªí²{ªº¶EÂ_¬O¤£¥i¯àªº¡C

·P¬V§C­P¯f©Ê¸V¬y·P¯f¬r«áªº¯f¼x©Î·|¬O½Ý°_¦Ð¤ò¡A³J²£¶qµu¼È´î¤Ö¡AÅé­«¤U­°­Ý¦³»´·Lªº©I§l¹D¯e¯f¯ë(Capua and Mutinelli 2001)¡C¤@¨Ç§C­P¯f©Ê«~ºØ¡A¦p¬Y¨ÇH9N2¨È¬w¥@¨t¡A¦b®a¸V¤¤¾AÀ³¤F°ª®Ä²v½Æ»s¡A¥i¯à·|¤Þ°_§ó¦hÅãµÛªº¼x¶H¥H¤Î­«¤jªº¦º¤`²v (Bano 2003, Li 2005)¡C

¦Ü©ó¨ä°ª­P¯f«¬¡A¦bÂû¤Î¤õÂûªº¯e¯f·|¦³¬ðµM¥X²{ÄY­«¯f¼x¤Î¦b48¤p®É¤º¯à¹F­P100%¦º¤`²vªº¯S¼x (Swayne and Suarez 2000)¡C¦b·P¬V¸sªº½¯©µµø¹}¾i§Î¦¡¦Ó©w: ¥Î´Ý¾lª«¤Î¦b¯àÅý°Êª«ª½±µ±µÄ²¤Î²V¦Xªº¦a¤è¹}¾iªº¯b¸s¡A¶Ç¬V¯fªº½¯©µ·|¸û¦bÅ¢¤¤¹}¾iªº§Ö¡A¦ý§¹¥þ·P¬V¤´»Ý¼Æ¤é (Capua 2000)¡C¦Ó¨ü¼vÅTªº©¹©¹¥u¦³¯bªÙªº¤@³¡¤À¡C«Ü¦h³¶³¾³£¬O¨S¦³¥ý¥ü¦a¦º¤`¡A©Ò¥H³Ìªì¦³®É·|ÃhºÃ¬O¥Ñ¤¤¬r¤Þ°_ªº (Nakatami 2005)¡C­È±oª`·Nªº¬O¡A¯S©wªº°ª­P¯f©Ê¸V¬y·P¯f¬r¹jÂ÷ª«©Î·|¦b¤@¸VÃþ«~ºØ¾É­PÄY­«ªº¯e¯f¡A¦ý¦b¨ä¥L«~ºØ«h¤£·|: ­»´äªº¬¡®a¸V¥«³õ¦b1997¦~µo¥Í¹ý©³ªº±Ú¸s¼Æ¥Ø´î¤Ö«e¡A20%Âû°¦¡A¦ý¥u¦³2.5%ÀnÃZ¡A§t¦³H5N1°ª­P¯f©Ê¸V¬y·P¯f¬r¡C¦Ó¨ä¥LÂû§Î¥Ø¡B³¶§Î¥Ø¤ÎÆx§Î¥Ø«~ºØªº¯f¬r´ú¸Õ¥þ³¡§e³±©Ê¡C¨Æ¹ê¤W¥u¦³Âû°¦Åã¥Ü¥X¦³Á{§É¯e¯f (Shortridge 1998)¡C

¦b¤u·~¤Æªº®a¸V¹}¾i¦a¡A¤ô¤Î­¹ª«®ø¯Óªº«æ³t¤W¤É«á¥X²{³vº¥¤U­°¯à°÷§@¬°¯b¸s¤¤¦s¦b¨t²Î©Ê¯e¯fªº«H¸¹¡C©ó¥Í³Jªº®a¸V¡A³J²£ªº°±¤î¬O¤Q¤À©úÅ㪺¡C­Ó§O·P¬V°ª­P¯f©Ê¸V¬y·Pªº³¶³¾³q±`·|®i²{¦h¤Ö³\ÄY­«ªº§N²H¤ÎÀR¤î (Kwon 2005)¡C¥i¨£©óÀY³¡¤[¯Ê¦Ð¤ò³¡¤Àªº¤ô¸~¡AÂû«a¡B¦×««¤Î»L³¡µoÖæ¡A§eºñ¦âªº¸¡Âm¤Î¦Y¤Oªº©I§l©Î·|¤£¤@­P¦a¦s¦b¡C¦b¥Í³Jªº®a¸V¡A³Ìªì·|¨£¨ì³n´ßªº³J¡A¦ýÀHþÓ¯e¯fªºµo®i¡A¥Í³Jªº¬¡°Ê·|¨³³t¦a°±¤î (Elbers 2005)¡CÃö©ó¯«¸g¨t²Îªº¯f¼x¡A¥]¬AŸ§Ý¡A¤£¥­±`ªº«º¶Õ (±×ÀV)¡A¥H¤Î¨ó½Õ°ÝÃD (¹B°Ê¥¢½Õ) ¦bÀn¡BÃZ¡B¥­¯ÝÃþµ¥©è§Ü¸û®zªº«~ºØªºª¬ªp¦û¤F¥D­nªº¦a¦ì (Kwon 2005)¡C1979¦~¦b¼w°ê¼»§J´µ¥§¨È¦{µo¥Íªº°ª­P¯f©Ê¸V¬y·PÃzµo¡A¦b¦À¶í¤¤ªºÃZ±j¨î¦a¶þÓ¯¶°é´å¤ô¬O³Ì¦­ªº©úÅã¼x¥ü¤¤¤§¤@¥H­Pªì³¡ÃhºÃ·P¬V°ª­P¯f©Ê¸V¬y·P¡C

¸V¬y·P·P¬V¤HÃþªºÁ{§Éªí²{·|¦b¡u¤HÃþ¬y·PÁ{§Éªí²{¡v (Clinical Presentation of Human Influenza) ³o¤@³¹¤¤¸Ô²Ó°Q½×¡C

 

¯f²z¾Ç

§C­P¯f©Ê¸V¬y·P

¾÷¯à»ÙêÀHþÓ¯f¬r«~ºØ¤Î±J¥DªººØÄݤΦ~ÄÖ¦ÓÅܤơC´¶¹M¨Ó»¡¡A¥u¦³¤õÂû¤ÎÂû°¦·|ªí²{¥XÅãµÛ¤Î·L¤pªº§ïÅÜ¡A¯S§O¬O¾AÀ³³o¨Ç±J¥Dªº«~ºØ (Capua and Mutinelli 2001)¡C¦b¤õÂû¤¤¡A¤w¬d¥X¦³»óÄuª¢¡B®ðºÞ ª¢¤Î®ðÅnª¢¡A¾¨ºÞ³o¥ç¥i¯à¬O¥Ñ¤G¯Å¯f¬r·P¬V¤Þ­P¡C¤õÂû¤¤ªº¯ØŦª¢¤w¦³©Ò´y­z¡C¦bÂû¤¤¡A©I§l¹Dªº»´·Lªº²o³s¬O±`¨£ªº¡C¦¹¥~¡A¥Í³Jªº¸V³¾ªº¾÷¯à»Ù궰¤¤©ó¥Í´Þ¾¹©x (§Z±_¡B¿é§ZºÞ¡B§Z¶À©Ê¸¡½¤ª¢)¡C

 

°ª­P¯f©Ê¸V¬y·P

°ª­P¯f©Ê¸V¬y·P¦b¯f²z¾Ç¤Î²Õ´¯f²z¾Ç¤WªºÅãµÛ§ïÅÜÅã¥Ü¥X»PÁ{§Éªí²{¬Û¦üªº¨Ì¿à©Ê¡C¼È®É¤w°²³]¥X¥|ºØ¯f²z¾Ç§ïÅÜ (Perkins and Swayne 2003) :

  1. «æ©Ê (·P¬V«á24¦Ü36¤p®É¤º¦º¤`¡A¥D­n¦bÂû§Î¥ØÆ[¹î±o¨ì) ¤Î¼@¯P«¬ªº¯e¯f¨S¦³Åã¥Ü¥X¯S§OÅãµÛªº¯f²z¾Ç§ïÅÜ: ¤£¤@­Pªº´y­z¡A¦³Â÷´²ªº¤ß¥]¿n¤ô¡A»´·L¸z¹Dªý¶ë¡A¸z¨t½¤¤Î¤ß¥]¼ß½¤°¸µM·ï´³¥X¦å (Mutinelli 2003a, Jones and Swayne 2004)¡C·P¬VH5N1¨È¬w¥@¨tªºÂû°¦¶¡¤¤·|®i²{¥X¦å´³¤Î®ðºÞ¤¤·|¥X²{¬Û·í¥÷¶qªºÂH²G (Elbers 2004)¡C¦bÅéµÄ¤ÎªÍ¤ô¸~¤]¥i¯à·|¥X²{¼ß²G©Êº¯¥Xª«¡C¹L©¹®ÑÂǤW±`±`¦³±Ô­zªº«e­GÂH½¤ªº¤Ö¶q¥X¦å¡A¥u¬O²§±`¦a¦b·P¬VH5N1¨È¬w¥@¨tªº®a¸V¸I¨ì (Elbers 2004)¡C³\¦h²Õ´¯f²z¾Çªº¾÷¯à»Ùê¥H¤Î¯f¬r§Ü­ì¥i¥H±q¤£¦P¾¹©x¤¤±´´ú±o¨ì (Mo 1997)¡C¯f¬r­º¥ý¬O¦b¤º¥Ö²Ó­Mµo²{¡C«á¨Ó¡A·P¬V¯f¬rªº²Ó­M¥i¥H±q¤ß¦Ù¡AµÇ¤W¸¢¤Î¯ØŦ¤¤´ú¥X¡C¯«¸g¤¸¥H¤Î¸£³¡½¦½è²Ó­M¤]·|¨ü·P¬V¡C­P¯f¾Ç¤W¡A¥i¥H°²©w»P¨ä¥L¤º¥Ö¯f¬r¦³¬Û¦üªº¶iµ{¡A§Y¤º¥Ö¤Î¥Õ¦å²y¬¡¤Æ·|¾É­P¨t²Î©Ê¤Î¤£¨ó½Õ¦aÄÀ©ñ²Ó­M¦]¤l¡A®e©ö¤Þ­P¤ßªÍ¤Î¦h¾¹©x°I°h (Feldmann 2000, Klenk 2005)¡C
  2. ªø®É¶¡¥X²{¯f¼x¤Î¯f±¡¯S§Oªøªº°Êª«¤¤¡A¯«¸g¨t²Îªº¯f¼x¤Î²Õ´¯f²z¾Ç¤Wªº«D¤ÆÁw©Ê¸£¾÷¯à·l®`¦û¤F¤@©wªº¦a¦ì (Perkins and Swayne 2002a, Kwon 2005)¡C¦ý¬O¡A¯f¬r¥ç¥i±q¨ä¥L¾¹©x¹jÂ÷¥X¨Ó¡C³o¹Lµ{¤w¦bÃZ¡BÀn¡B¤õÂû¤Î¨ä¥L¹êÅç¤W·P¬V°ª­P¯f©Ê¸V¬y·PH5N1¨È¬w¥@¨tªººØÄݤ¤¦³©Ò´y­z¡C¦Ü©ó¥Í³Jªº³¾Ãþ¡A·|¥X²{§Z±_¡B¿é§ZºÞªºµoª¢¡A¥H¤Î¦b§Zªw¯}µõ«áªº©Ò¿×§Z¶À©Ê¸¡½¤ª¢¡C
  3. ¦bÀn¡BÅäήa®x³Â³¶¡A¥uµo²{¦³­­¨îªº¯f¬r½Æ»s¡C³o¨Ç³¶³¾Åã¥Ü¥X»´·Lªº¶¡½è©ÊªÍª¢¡A®ðÅnª¢¥H¤Î¶¡·²©Ê²O¤Ú¤Î²Õ´²Ó­M¤ß¦Ùª¢ (Perkins and Swayne 2002a, 2003)¡C
  4. ¦bPerkins©MSwayne (2003) ªº¹êÅç³ø§i¤¤¡AÃÒ¹êÂF¤l¤Î¼Ú±°³¾¯à©è§ÜH5N1ªº·P¬V¡CµM¦Ó¡AWernerµ¥¤H (±N·|¥Zµn) ¯à°÷¥Îªñ´Á¦L¥§ªº°ª­P¯f©Ê¸V¬y·PH5N1¹jÂ÷ª«¦b5/16ªºÂF¤l¤¤¡A¦]«D¤ÆÁw©Ê¸£ª¢¡A¤Þ°_«ùÄòªº¯«¸g¨t²Î¯e¯f (Klopßeisch 2006)¡C

 

Ų§O¶EÂ_

¦b°ª­P¯f©Ê¸V¬y·PªºÅ²§O¶EÂ_¤¤¡A¦]¬°¥H¤Uªº¯e¯f¦³¯à¤O¤Þ°_¦ñÀH°ª¦º¤`²v©ÎÂû«a¤Î¦×««·ï¦åªº¯e¯f¬ðµMµo¯f¡A©Ò¥H¤@©w­n¦Ò¼{¥¦­Ì:

  • ±j¬r®è¯Ã¥d¯ÀÂû½E
  • ¶Ç¬V©Ê³ï®ðºÞª¢ (Âû)
  • Àn½E
  • «æ©Ê¤¤¬r
  • «æ©Ê®a¸VÀN¶Ã (¤Ú´µ¼w¤óµß¯f) ¤Î¨ä¥L±Ñ¦å¯g¯e¯f
  • Âû«a¤Î¦×««ªº²Óµß©Ê¸ÁºÛ²Õ´ª¢

¸û¤£ÄY­«ªº°ª­P¯f©Ê¸V¬y·PÃþ«¬¦bÁ{§É¤W¥i¥H§ó²V¶Ã¡C©Ò¥H¡A§Ö³tªº¹êÅç¶EÂ_¤ä´©¹ï©Ò¦³¶i¤@¨Bªº´ú¶q³£¤Q¤À­«­n (Elbers 2005)¡C

 

¹êÅç¶EÂ_

¦¬¶°¼Ë¥»

¼Ë¥»À³¥Ñ·sÂAªº°Êª««ÍÅé¤Î¯f³¾¸s¦¬¶°¡C²z·Q¦a¡A¾A·í©â¼Ë¬O¦³²Î­p¤Wªº¤ä«ù¦Ó¶EÂ_¬O¨Ì¾Ú¸V¸sªº¡C·í¸ÕÅç¼Ë¥»ÃhºÃ¦s¦³°ª­P¯f©Ê¸V¬y·P®É¡A¤@©w­nª`·N¦w¥þ¼Ð·Ç¨ÓÁקK¼Ë¥»¦¬¶°ªÌ±µÄ²¨ì¼ç¦bªº°Êª«¤HÃþ¾Çªº°ª­P¯f©Ê¸V¬y·P¯f¬r (Bridges 2002)¡C¬ü°ê¯e¯f¨¾ªv¤¤¤ß¤w´£¥X¬ÛÃöªº«ü¤Þ (CDC 2005)¡C

¹ï©ó¯f¬r¾Ç¤ÆÅç¡A¥Ñªn´ÞµÄ¤Î¤f«|Àò±oªº«ø¤l¤@¯ë·|¦Ò¼{¨ì¥i¾aªº¹êÅç¬ã¨s¡C«ø¤l¤W¦¬¶°¨ìªºª«½èÀ³²V¦X©ó2-3²@¤É§t¦³§Ü¥Í¼W¸É¤Î³J¥Õ·½ (¦p 0.5% [­«¶q¹ïÅé¿n¤ñ] ¤û¦å²M³J¥Õ¡A¦h¦Ü 10% ¤û¦å²M©Î¸£¤ß®û²G)ªºµLµßµ¥º¯À£¹B°e²G¤¤¡C

¦b¦w¥þ¤ÎÁקK¯e¯f´²¼½ªº±¡ªp¤U¶i¦æÅç«Í¡A¥i¥H¦¬¶°¨ì¸£¡B®ðºÞ/ªÍ¡BµÊŦ¤Î¸z§t¶qªº¨S«OÂü˥»¨Ó¹jÂ÷¥X¯f¬r¡C

°ò©ó¦å²M¥Î³~¡A·|©â¨ú¨ä¤ÑµMªº¦å²G¼Ë¥»¡C¦¬¶°¨ìªº¼Ë¥»¼Æ¶qÀ³¨¬°÷©ó¦³30%¬y¦æµ{«×ªº¦]¯À¹F¨ì95%¸m«H°Ï¶¡ªºÀË´ú¡C

 

¼Ë¥»¹B¿é

«ø¤l¡B²Õ´¤Î¦å²GÀ³¥H§N­á¦ý¤£µ²¦Bªº±¡ªp¤U¹B¿é¡C­Y¹w­p¦b¹B°e¶iµ{¤¤·|¦³¶W¹L48¤p®Éªº©µ»~¡A³o¨Ç¼Ë¥»À³­n­áµ²¤Î¥H°®¦B¶i¦æ¹B¿é¡C¦b¥ô¦ó±¡ªp¤U¡AÀ³¸Ó¤@µ·¤£­e¦a¿í¦u¥æ³q¦w¥þ³W«h (e.g. °ê»ÚªÅ¹B¨ó·|±ø¨Ò) ¨ÓÁקK¦b¹B¿é¹Lµ{¤¤¶Ç¼½¯e¯f¤Î·N¥~¦a±µÄ²¨ì­û¤u¡C¦b±H¥X¼Ë¥»«e¡A¬Æ¦Ü§ó²z·Q¦a¡A¦¬¶°¼Ë¥»«e¡A¨Æ¥ýÁpµ¸«ü©wªº¶EÂ_¹êÅç«Ç¬O«D±`¾A·íªº¡C

 

¶EÂ_¯ÅÁp

¸V¬y·P¯f¬r·P¬Vªºª½±µÀËÅç

°ò¥»¤W¡A¦³¨âºØ (¬Û¦ü) ªº¶EÂ_´ú¶q¤èªk¸Õ¹Ï¥h (i) ¥Î¶Ç²Îªº¤èªk¹jÂ÷¯f¬r¤Î½T©w¨ä¨È«¬¥H¤Î (ii) ±q¤À¤l§Þ³Nªº¤èªkÀË´ú¤Î¤À¿ë¯f¬rªº°ò¦]²Õ¡C

(i) ·ÓºD¨Ò¡A¸V¬y·P¯f¬r¬O¹jÂ÷¦Û³q±`¸gµ³¤ò§¿Ånªº³~®|¡A±N«ø¤l²G©Î²Õ´¤Ã¼ß±µºØ¦Ü9¦Ü11¤é¤j¨ã­F­LªºÂû³Jªº¹Lµ{ (Woolcock 2001)¡C¨Ì­P¯f«¬¡A¦b5¤éªºÆ[¹î´Á¤º­F­L·|©Î¤£·|¦º¤`¡A¦Ó³q±`¦b­F­L¤Î§¿½¤³£¨S¦³¯S§Oªº¾÷¯à»Ùê (Mutinelli 2003b)¡C±µºØ¤F§t¦³°ª­P¯f©Ê¸V¬y·P¯f¬rªºª«½èªº³J¡A³q±`·|¦b48¤p®É¤º¦º¤`¡C¦b©Ò±oªº§¿Ån©]¤¤´ú¥X¦³¾®¦å¾¯ªº¦s¦b¡C¦å¾®¤ÏÀ³ (haemagglutination, HA) ¬O¤@­Ó¤£±Ó·Pªº§Þ³N¡A»Ý­n¨C²@¤É¦³³Ì¤Ö106.0²É²É¤l¡C¦p±µºØÅ餤¥u¦³§Cªº¯f¬r¿@«×¡A¬Y¨Ç§C­P¯f©Ê¸V¬y·P¯f¬r«~ºØ©Î»Ý­n³Ì¦h¨â¦¸¶i¤@¨B³q¹L¨ã­F­Lªº³J¡A¬°¤F¯à¦³¨¬°÷ªº¯f¬r¨ÓÅýHAÀË´ú±o¨ì¡C¦Ü©ó°ª­P¯f©Ê¸V¬y·P¯f¬r¡A¥Îµ}ÄÀªº±µºØÅé°µ²Ä¤G¦¸ªº³q¹L©Î¦³§Q©ó¾®¦åªº²z·Q²£¥Í¡C

¾®¦å¹jÂ÷ª«³q¹L§Ü¾®¦å´ú¸Õ (HI test) ¦b§Ü­ì¤W¤À¿ë¡A¹ï16H¨È«¬¡A©Î¹ï·Óª«¹ï¦P¼Ë®i²{¾®¦å§@¥Îªº¤£¦PºØÃþ¸VÃþ°ÆÂH²G¯f¬rªº(³æ)¯S²§§Ü¦å²M¡C¯«¸gÓi»ÄžJ¤ÆÅç¡A¦P¼Ë»Ý­n¨È«¬¯S²§¦å²M¡A¥i¦b¨ä«á´ú©w¥XNA¨È«¬ (Aymard 2003)¡C°²¦p¹J¨ìH5©ÎN7¥@¨tªº¹jÂ÷ª« ¡A»Ý­n´ú©w¨äÀR¯ß­P¯f«ü¼Æ (intravenous pathogenicity index, IVPI) ¨Ó¤À¿ë§C­P¯f©Ê¤Î°ª­P¯f©Êªº¥Íª««¬ (Allan 1977)¡C³o¥i¥H¥Ñ10°¦6¶g¤jªºÂû»P¦b³J¥Íªøªº¯f¬r¹jÂ÷ª« (0.1²@¤É1¤ñ10§t¦³¶W¹L1¤ñ16HAºw©w«×ªº§¿Ån²G)ªºÀR¯ß±µºØ¹F¨ì¡C³o¨ÇÂû°¦·|³QÆ[¹î¶W¹L10¤é¨Ó¬d¬Ý¨äÁ{§É¯f¼x¡C¨äµ²ªG·|¦X¨Ö¬°«ü¼Æ¡AÀò±oªº¼Æ­È¤j¹L1.2ªº¸Ü´Nªí¥Ü¦³°ª­P¯f©Ê¸V¬y·P¯f¬r¡C©ÎªÌ¡A·í³Ì¤Ö10¤À¤§7 (75%) ¤w±µºØªºÂû¦bÆ[¹î´Á¶¡¦º¤`¡A´N¥Nªí¹J¨ì°ª­P¯f©Ê¸V¬y·P¯f¬r¹jÂ÷ª«¡C

¤w´y­zªº¶Ç²Î¨BÆJ¯à­P¨Ï5¤Ñ¤ºªº°ª­P¯f©Ê¸V¬y·P¶EÂ_¡A¦ý©Î­n¶W¹L¨â¬P´Á¨Ó±Æ°£¸V¬y·P¯f¬rªº¦s¦b¡C¦Ó¥B¡A°ª«~½èªº¶EÂ_¤u¨ã (SPF³J¡AH¤ÎN¨È«¬¯S²§§Ü¦å²M) ¤Î°ª§Þ³N¤H­û¬O¤£¥i¯Ê¤Öªº¡C²{¦b¡A¨S¦³¯à¹F¨ì¨ã­F­LÂû³Jªº±Ó·P«×ªº²Ó­M°ö¾iÀ³¥Î¤èªk¨Ó¹jÂ÷¸V¬y·P (Seo 2001)¡C

(ii) ¤@­Ó§ó§Ö±¶ªº¤èªk¡A¯S§O¬O»Ý­n±Æ°£·P¬V®É¡A´N¬O§Q¥Î¦P¼Ë¨Ì·Ó¯ÅÁp§Î¦¡ªº¤À¤l§Þ³N: ³q¹LÂê©w³Ì°ª«OÅ@ªº¬y·P¯f¬r°ò¦]²Õ¤À¸` ¢w M°ò¦]³¡¥÷ªº°fÂà¿ý»E¦XžJÁä¤ÏÀ³ (RT-PCR) (Fouchier 2000, Spackman 2002)¡A©Î®Ö¦ç´ß°ò¦] (Dybkaer 2004)¡AÀË´ú¥X¥Ò«¬¬y·P¯S²§RNAªº¦s¦b¡C·í§e¶§©Ê¤ÏÀ³®É¡A·|¨Ï¥Î©ñ¤jH5¤ÎH7¨È«¬ªº¦å¾®¯À³J¥Õ°ò¦]³¡¤ÀªºRT-PCR¨ÓÀË´ú¥X¥²»Ý³ø§i½Ã¥Í·í§½ªº¸V¬y·P¯f¬rªº¦s¦b (Dybkaer 2004, Laboratory Diagnosis 61 Spackman 2002)¡C¦p¤S§e¶§©Ê¡A¦b±Æ§Ç¸ó¶V¤º³J¥Õ°Å¤Á¦ìÂIªºHA°ò¦]³¡¤À«á¡A¥i¹ê¦æ¨ä­P¯f«¬ (§C­P¯f«¬¹ï°ª­P¯f«¬) ªº¤À¤l¶EÂ_¡CÅã¥Ü¦³¦hºØÆP©Ê®ò°ò»Äªº¹jÂ÷ª«·|³Q¤ÀÃþ¬°°ª­P¯f­P¸V¬y·P¡CPCR¤Î¨ä¥LDNA´ú¸Õ§Þ³N¥¿³Q³]­p§@H5N1¨È¬w¥@¨t«~ºØªºÀËÅç¤èªk (Collins 2002, Payungporn 2004, Ng 2005)¡C«DH5/H7¨È«¬¥i¥H¥Ñ¼Ð·ÇªºRT-PCR¥H¤ÎÀH«áªºHA-2¨È³æ¦ì§Ç¦C¤ÀªR½T»{ (Phipps 2004)¡C¦Ó¥BÁÙ¦³¹ï¨CºØNA¨È«¬ªº¯S©w¤Þ¤l¡C§¹¾ãªº´y­z©Î¥i¦b¤T¤Ñ¤º§¹¦¨¡A¤×¨ä¬O¨Ï¥Î¹ê®ÉPCR§Þ³N(Perdue 2003, Lee and Suarez 2004)¡CµM¦Ó¡A¯à°÷¶i¤@¨B´£°ª¸V¬y·P¯f¬r¤ÀªR®Ä²vªºDNAÁ¡¤ù¥¿¦bµo®i·í¤¤ (Li 2001, Kessler 2005)¡A¨Ï±Æ°£¶EÂ_¯à¦b¤@­Ó¤u§@¤Ñ¤º§¹¦¨¡C

¤À¤l¶EÂ_¤èªkªº¯ÊÂI¬O¥Î¨ÓÁʶR»ö¾¹¤Î®ø¯Ó«~ªº»ù®æ¡C¤£¹L¡A­Y°µ±o¨ì¡A¬Û¹ï¦b³J¤¤¹jÂ÷¯f¬r¡A«Ü¦h¼Ë¥»¯à°÷¥Ñ¸û¤Öªº­û¤u¦b·¥µu®É¶¡¤º¶i¦æ¤ÀªR¡C¦ý¬O¡A¤£¯à¤£©Ó»{¡A»P³J¤¤¹jÂ÷¯f¬r¬Û¤Ï¡A¨C­ÓPCR©ÎÂø¥æ¤ÏÀ³¥]§t¤FÃö©ó¹jÂ÷ª«¦b¤Þ¤l¤Î/©Î±´°wµ²¦X¦ìÂI¦s¦b¯S©w¬ðÅܪº¤º¦b¤£½T©w¦]¯À¡A©Î·|¾É­PÀË´ú¥¢±Ñ¤Î§e³±©Ê¡C

©Ò¥H¡AÁp¦X¤À¤l (e.g. §@¿z¿ï¥Î³~) ¤Î¶Ç²Î¤èªk (e.g. §@³Ì«áªº¹jÂ÷ª«¤À¿ë¤Î¦b«ü¼Æ¤W§@¶EÂ_½T»{) ¥i¯à¦³§U©ó©è®ø³o¨âºØ­ì²zªº¯ÊÂI¡C

§Ö³t´ú¸Õ¤w³Q³]­p¥X¥H§K¬Ì¿Ã¥úªk§@²Õ´¦L¶î¤ù¤Î§C·Å¤Á¤ùªº¯f¬r§Ü­ìÀË´ú¡A©Î¥Î§ÜÅé®·®»žJÁp§K¬Ì§lªþ´ú©w (ELISA) ¤Î«ø¤l²Gªº¸Õ±ø°¼¦V¬y°Ê¨t²Î¡C¨ì¥Ø«e¬°¤î¡A³o¨Ç§Þ³N¸û¯f¬r¹jÂ÷©ÎPCR¤£±Ó·P¡A©Ò¥H©Î³\¸ûÃøÀò§å­ã§@¨ã¦³ªk«ß¤W¬ù§ôªº¶EÂ_¡A ¤×¨ä¬O«ü¼Ðªº­Ó®× (Davison 1998, Selleck 2003, Cattoli 2004)¡C¥Îµ§°¼´ú¸ÕÅç¦bÃ~Âå¬Éªº¨Ï¥Î¤]¥u¬O¦bªì´Á¶¥¬q¡A¦Ó¥B»Ý­n¶i¤@¨Bªºµo®i¡C

 

¸V¬y·P¯f¬r·P¬Vªº¶¡±µÀËÅç

®Ú¾Ú¯b¸sªº¦å²M¾Ç©Î¦³§U©ó¿z¿ï¥Î³~ (Beck 2003)¡C¦Ü©ó³¶³¾¦å²M¼Ë¥»¡A©Î¥Í³J¸V³¾ªº§Z¶À¤¤ªº¸V¬y·P¯f¬r¯S²§§ÜÅé´ú¸Õ¡A§Q¥Î°Ñ¦Òªº¨È«¬§Ü­ìªº§Ü¾®¦å (HI) ¤ÆÅ礴µM¥Nªíþӳ̦nªº¶Àª÷¼Ð·Ç¡C¹ï®Ö¦ç´ß³J¥ÕªºÃþÄݯS²§©Ê§ÜÅé (¥Ò«¬¬y·P¯f¬r) ¤]¥i¥Ñã¯×¾®½¦§K¬Ì¨I¾ý¤ÏÀ³¤ÎžJÁp§K¬Ì§lªþ´ú©w (ELISA) ÀË´ú¥X (Meulemans 1987, Snyder 1985, Jin 2004)¡CÄvª§©ÊªºELISA§Î¦¡¤¹³\©Ò¦³³¾Ãþ«~ºØ¦å²MªºÀˬd¡A¤£¨ü¨î©óºØÄݯS²§ºó¦Xª«ªº¥i±o©Ê (Shafer 1998, Zhou 1998)¡C²{¦³³ø¾É¤@ºØ±M¬°H7§ÜÅéÀËÅ窺ELISA§Î¦¡ (Sala 2003)¡A¦ý²{¦b¤´¨S¦³¨ººØ¥i¥H¥Î§@¸V³¾¦å²M±M¬°H5¯S²§§ÜÅ骺ÀËÅç¡C

¨È«¬¯S²§§ÜÅé°Ê¤O¾Çµø¥G¯f¬rºØªº¯S¼x¤Î¥D­nµø¥G±J¥DºØÃþ¦Ó©w¡C¦bÄLÂûÃþ¸V³¾¤¤¡A¸V¬y·P¯S²§§ÜÅé¦bºòÀH¯f¬r¤J«Iªº¨â­Ó¬P´Á¤º½T¹ê¦aÅܱo¥iÀË´ú¨ì; §Z¶À¤ºªº§ÜÅé¦b©µ»~¼Æ¤é«á¥i¥HÀË´ú±o¨ì (Beck 2003)¡CÀn¬ìºØªº§ÜÅé²£¥Í¤ÎÀËÅç§ó¬O¦hÅÜ (Suarez and Shultz-Cherry 2000)¡C

 

·P¬V

³¶³¾¶¡ªº·P¬V

§C­P¯f©Ê½d³òªº¸V¬y·P¯f¬r¦b³¥¥Í¤ô¸Vªº¿ò¶Ç¤Wí©w (Webster 1992)¡C³¾Ãþ¶¡ªº·P¬V¶g´Á¨Ì±Æªnª«¤Î¤fµÄ¶Ç¼½Ãì¦Ó©w¡C°£±J¥D¨ì±J¥Dªºª½±µ¶Ç¼½¥~¡A³q¹L¨ü¯f¬r¦Ã¬Vªº¤ô¤Î¦Ã¬Vª«ªº¶¡±µ½¯©µ¬O¤@­Ó­«­nªº³~®|¡A»P­÷¨ÅÃþ°Êª« (¤H¡B½Þ¡B°¨) ´¶¹M¥Ñ­¸ªj¶Ç¼½ªº¬y·P¯f¬r·P¬V¤£¦P¡C¦b³¾Ãþ¡A´ú¶q¥X¦b¨C§JÁT«K¤¤§t¬Û·í©ó108.7 x 50%¸V­F·P¬V¶q (EID50) ªº³Ì°ªªº±Æªnºw©w«× (Webster 1978)¡C¥­§¡ºw©w«×«h§ó¤j´T«×¦a§C¨Ç¡C¸V¬y·P¯f¬rÅã¥Ü¥X¤@­Ó¥O¤H¾_Å媺¡A¦bÀô¹Ò¤¤¤]¯à«O¦s­P¯fªº¯à¤O¡A¯S§O¬O¤ô­±¤]¥i«O¯d¶Ç¬V©Ê¡AÁöµM¨ä§ÎºA¾Çªí­±¤W¦ü¥G¬O¯Ü®zªº (Stallknecht 1990a+b, Lu 2003)¡C¤ô¤¤ªº¯f¬rÄa¯B²G¤wÃÒ¹ê¦b17¢J·|«O¯d¶Ç¬V©Ê¶W¹L100¤é¡C¯f¬r¥i¦b§C©ó-50¢JµL­­´Á¦aÀx¦s°_¨Ó¡C®Ú¾Ú Itoµ¥¤H (1995) ¤Î Okazakiµ¥¤H (2000)ªº¼Æ¾Ú¡A´£¨Ñ¤FÃÒ¾ÚÅã¥Ü¸V¬y·P¯f¬r¦b¥j¥_°Ïªº¥V¤Ñ¡A¦b¯Ê¥F¨ä¾E²¾¤ÑµM±J¥Dªº±¡ªp¤U ¡A¬O«O¦s©óµ²¦Bªº´ò¤ô¡C¦bÀH«á©u¸`¬°¤FÁc´Þ¦Ó¦^Âk«á¡Aªð¦^³~¤¤ªº³¶³¾¤Î¨ä©ö¨ü¼vÅTªº«á¥N¦A·|°¸µM¦a³Q·»¤ÆªºÀô¹Ò¤ô·½ÄÀ¥Xªº¯f¬r·P¬V¡CªuþÓ³o¨Ç¤è¦¡¡A¤w¦³°²³]»¡¸V¬y·P¯f¬r¯à«O¦s©óÀô¹Ò¦B¤@¬q¯S§Oªøªº®É¶¡ (Smith 2004)¡A¦Ó¥B©Î·|±q³oÀx¦s®w±N¥j¥Nªº¯f¬r¤Î°ò¦]«¬´`Àô§Q¥Î (Rogers 2004)¡C

¥Íª«¦w¥þ±¹¬I ¡A¦®¦b¹jÂ÷¤j¶q®a¸V¾i´Þ³õ¡A¦³®Ä¦a¹w¨¾ªª³õ¶¡ªºª«²z¤è¦¡¶Ç¼½¡A¦p¨ü¦Ã¬Vªº³]³Æ¡A¥æ³q¤u¨ã¡A¹}®Æ¡AÅ¢¡A©Î¦çªA¡A¯S§O¬O¾c¡C1999/2000¦~ªº·N¤j§Q°ª­P¯f©Ê¸V¬y·P®a¸V¬y¦æ¯fªº¤ÀªRÅã¥Ü¥X¤U¦Cªº¶Ç¼½­·ÀI: ¨ü·P¬V¸V¸sªº²¾°Ê (1.0%)¡A®a¸V¹B¿é¦Ü±O®_³õ³~¤¤ªº¶¡±µ±µÄ² (8.5%)¡A¨ü·P¬V¸gÀç³õ¦aªº¤@¤½¨½¥b®|¾Fªñ¦a°Ï (26.2%)¡A¥Î§@¹B°e¹}®Æ¡B¹Ô¯ó©Î°Êª««ÍÅ骺³f¨® (21.3%)¡A¨ä¥L³q¹L¾­û¡B¤u§@¾¹±ñ¥æ´Àªº¶¡±µ±µÄ²µ¥(9.4%) (Marangon and Capua 2005)¡C¹ï·N¤j§Q®a¸V¬y¦æ®ÉªºªÅ®ð¶Ç¼½¨S¦³µ¹¤©¥ô¦ó½u¯Á¡CµM¦Ó¡A¦b²üÄõ (2003) ¤Î¥[®³¤j (2004) ªºÃzµo¡A´N¦Ò¼{¨ìªÅ¤¤ªº¶Ç¼½ (Landman and Schrier 2004, Lees 2004)¡C¬¡¶Ç¬V´C¤¶¡A¦pÅj¾¦¥Ø°Êª«©Î»aÃÇ¡A©Î·|¥R·í¡u¾÷±ñ©Ê¶Ç¬V´C¤¶¡v¦Ó¥L­Ì¦Û¤v¤£·|¨ü·P¬V¡A¨ä§@¥Î¤´¥¼²M·¡¦a½T©w¡A¦ýªÖ©w¤£·|ºc¦¨­«­nªº¦]¯À¡C

°ª­P¯f©Ê¸V¬y·P¯f¬r¥Ñ®a¸V¦A¦¸¶Ç¤J³¥³¾¸s¨Ã¤£ÅãµÛ¡Aª½¦Ü°ª­P¯f©Ê¸V¬y·P¯f¬rH5N1¨È¬w¥@¨tªº¥X²{¡C¦ý¬O¡A2005¦~4¤ë¡A¥X²{©ó¤¤°ê¦è¥_³¡«C®ü´òªºH5N1¨È¬w¥@¨tÃöÁpªº¯e¯f¡A¼vÅT¨ì¼Æ¤d°¦´³ÀY¶­¤Î¨ä¥LÀn¡Bù·õ¬¡BÅ꺾E²¾«~ºØ (Chen 2005, Liu 2005)¡C¦]¦¹¡A¦b¤é«áªº¹w¨¾Æ[©À¤º¡A¤@©w­n¦Ò¼{¨ìH5N1¨È¬w¥@¨t¯f¬r¸g³¥³¾¶Ç¼½ªº³~®| (¦b¤U­±·|°Q½×)¡C

¦Û±q2003¦~¥½¡A¦b¨È¬wµo²{ªº¤@¨ÇH5N1¯f¬r¡A¹ïÂû¦³°ª­P¯f©Ê¡A¦ý¹ïÀn«h¤£¬O(Sturm-Ramirez 2005)¡C§Q¥Î³o¨Ç¹jÂ÷ª«ªº¹êÅç©Ê·P¬VÅã¥Ü¥X¬Û¹ï©ó°ò¦]¤ÀªR¤Î²Ó­M°ö¾i¤¤·»µß´³§Î¦¨¯à¤Oªº²§ºØ²V¦X (Hulse Post 2005)¡C±q³o¨Ç¹jÂ÷ª«·P¬V¥Í¦sªºÀnÃÒ¹ê·|¦b²Ä17¤é¥h°£¥¢¥h¹ïÀn¦³­P¯f¯à¤Oªº¯f¬r±Ú¸s¡C·í¥ÎÁ{§É¯gª¬¨Ó¿z¿ïªª³õ¤¤°ª­P¯f©Ê¸V¬y·P¯f¬rH5N1ªº¦s¦b®É¡AÀn¦³¥i¯àÅܦ¨¯f¬rªº¡u¤ì°¨¡v (Webster 2006)¡C

 

¹ï¤Hªº·P¬V

¸V¬y·P¯f¬r¶Ç¬V¤HÃþ¡A¤Þ­PÁ{§É¤W©úÅ㪺¯e¯f¬O¤Q¤À¨u¦³ªº (ªí¤T)¡C¦bªF«n¨È¼Æ¥H¦Ê¸Uªº¤H¦³¼ç¦b¥i¯à¼ÉÅS©ó°ª­P¯f©Ê¸V¬y·P¯f¬rH5N1¡A¹ê»Ú¤W¤½§Gªº¤HÃþ­Ó®×¼Æ¦r¡AÁöµM¦b¹L¥h´X¦~¤£Â_¼W¥[¡AÀ³¤´³Qµø¬°¬Û¹ï¦a§C(http://www.who.int/csr/disease/avian_influenza/country/en)¡C

°ª­P¯f©Ê¸V¬y·P¯f¬rH5N1¨È¬w¥@¨t»P¤HÃþ©I§l¹D¯e¯fªºÃö«Y­º¥ý¦b1997¦~©ó­»´äÆ[¹î¨ì¡A·í®É¨üH5N1·P¬Vªº18¤H¤¤¦³6¤H¦º¤`¡C³o¨Ç­Ó®×¦b¬y¦æ¯f¾Ç¤W»P¬¡®a¸V¥«³õªº°ª­P¯f©ÊH5N1Ãzµo¦³Ãö (Yuen 1998, Claas 1998, Katz 1999)¡C¹ï©ó»P¨ü·P¬Vªº¬¡®a¸V¡B³Q¨äÁT«KÄY­«¦Ã¬Vªºªí­±©Îª«¥ó¦³±K¤Á±µÄ²ªº¤H¡AH5N1¯f¬r¥Ñ³¶³¾·P¬V¤HÃþªº­·ÀI³Ì°ª¡C±O®_¡B¥h¤ò¡B³c½æ©Î·Ç³ÆµN­¹¹Lµ{ªº¼ÉÅS­·ÀI³Qµø¬°°ª (http://www.who.int/csr/don/2005_08_18/en/)¡C°ª­P¯f©Ê¸V¬y·PH5N1¨È¬w¥@¨t¯f¬r¯à°÷¦b³¶³¾«ÍÅ骺©Ò¦³²Õ´ ¢w ¥]¬A­¹¥Îªº¦×¤¤§ä¨ì¡C¦b¤@¨Ç¨Ò¤l¤¤¡A¦³³ø§i«ü¥X±N¯f³¾±O®_©Î·Ç³Æ§@­¹¥Îªº¤Hµo®i¥X­P©Rªº¯e¯f¡A¦ý¤@°_¥Î¿¯ªº®a®x¦¨­û«h¤£·| (http://www.who.int/csr/don/2005_10_13/en/index.html)¡C

ªí¤T. ¤w¤½§Gªº¸V¬y·P¯f¬r¤HÃþ·P¬V*

¤é´Á °ê®a/¦a°Ï «~ºØ ­Ó®× (¦º¤`) ¯gª¬ ·½ÀY
1959 ¬ü°ê H7N7** 1 ©I§l¹D ®ü¥~®È¹C
1995 ­^°ê H7N7 1 µ²½¤ª¢ Ãdª«Àn (»P¾E±p³¶³¾¤À¨É´ò¤ô)
1997 ­»´ä H5N1** 18 (6) ©I§l¹D/ªÍª¢ ®a¸V
1998 ¤¤°ê (¼sªF) H9N2 5 ¤£¸Ô ¤£¸Ô
1999 ­»´ä H9N2 2 ©I§l¹D ®a¸V; ¤£¸Ô
2003 (¤G¤ë) ­»´ä H5N1** 2 (1) ©I§l¹D ¤£¸Ô
2003 (¤T¤ë) ²üÄõ H7N7** 89 (1) µ²½¤ª¢ (­P©R­Ó®×·|¦³ªÍª¢¤Î©I§l¤£¨¬) ®a¸V
2003 (¤Q¤G¤ë) ­»´ä H9N2 1 ©I§l¹D ¤£¸Ô
2003 ¯Ã¬ù H7N2 1 ©I§l¹D ¤£¸Ô
2003 ¶V«n H5N1** 3 (3) ©I§l¹D ®a¸V
2004 ¶V«n H5N1** 29 (20) ©I§l¹D ®a¸V
2004 ®õ°ê H5N1** 17 (12) ©I§l¹D ©I§l¹D
2004 ¥[®³¤j H7N3** 2 µ²½¤ª¢ ®a¸V
2005 ¶V«n H5N1** 61 (19) ©I§l¹D ®a¸V
2005 ®õ°ê H5N1** 5 (2) ©I§l¹D ®a¸V
2005 ¤¤°ê H5N1** 7 (3) ©I§l¹D ®a¸V
2005 ¬Z®H¹ë H5N1** 4 (4) ©I§l¹D ®a¸V
2005 ¦L¥§ H5N1** 16 (11) ©I§l¹D ®a¸V
2006 ¤g¦Õ¨ä H5N1** 3 (3) ©I§l¹D ®a¸V

* ¨Ó·½: Avian influenza - assessing the pandemic threat. WHO, http://www.who.int/csr/disease/influenza/WHO_CDS_2005_29/en/, µn¤J 06 January 2006
**¹ï®a¸V¦³°ª­P¯f©Ê

¤@­ÓH9N2«~ºØ¦b1999¦~®É­»´ä¯S§O¦æ¬F°Ïªº¨â¦W¤pµ£¡A¥H¤Î2003¦~¤Q¤G¤ë¤¤®É¤@¦W¤pµ£¡A¤Þ°_¤F»´·Lªº¡A¬y·Pª¬ªº¯f¼x (Saito 2001, Butt 2005)¡C³o¨Ç´Á¶¡¬y¶Ç©ó®a¸VªºH9N2«~ºØ¡A¦b¤õÂû¤ÎÂûµ¥©è§Ü«D±`®zªº«~ºØ¡A¾É­P¤F­«¤jªº¯f¼x¤Î­P©R²v¡C

®Ú¾Ú¬ö¿ý¡A¨S¦³ÃÒ¾ÚÅã¥Ü«ê·í¦aµN¼ôªº®a¸V¦×Ãþ©Î®a¸V»s«~¬OH5N1¨È¬w¥@¨t¤HÃþ·P¬Vªº·½ÀY¡C¨Ì·ÓºD¨Ò¡AWHO«Øij­n±N¦×Ãþ¹ý©³µN¼ô¡A¥O¦×Ãþªº©Ò¦³³¡¤À³£¹F¨ì70¢J¤º³¡·Å«×¡C¦b³o·Å«×¡A¬y·P¯f¬rÅܱo¥¢¬¡¡A¦]¦¹Åܱo¦w¥þ¡AÁקK­Y¤z¥Íªº®a¸V¦×Ãþ¨üH5N1¯f¬r¦Ã¬V (WHO 2005)¡C

 

¹ï¨ä¥L­÷¨ÅÃþ°Êª«ªº·P¬V

¸V¬y·P¯f¬r¦b¤@¨Ç±¡ªp¤U·|¶Ç¬V¨ì¤£¦Pªº­÷¨ÅÃþºØÄÝ¡C³o®É¡A±µþӽƻs¤Î¾AÀ³¶g´Á¡A·|µo²{·sªº¬y¦æ¥@¨t¡C¤×¨ä¬O½Þ¡AÀWÁc¦a²o¯A¤J¨ººØ¡uºõ¶¡ÄA´«¡v¡C¦b¼Ú¬wªº½Þ¸s¤¤¡AÃþ¦ü¸VÃþªºH1N1¯f¬r¬O°ª«×²±¦æªº (Heinen 2002)¡C¦Ó1992¦~¦b­^°ê­º¦¸¹jÂ÷ªº¤HÃþ¸V³¾­«±ÆÅé¯f¬r¡AH1N2¯f¬r¡A¥¿«ùÄò¦a¼W²K»â°ì (Brown 1998)¡C¦b¬ü°ê¡A¥¿¬y³qþӶDzÎH1N1¡B¤HÃþH3N2¤Î¸V³¾¨È«¬¶¡ªº¤T­«­«±ÆÅé (H3N2) (Olsen 2002)¡C¨ä¥L¤j·§¬O·½©ó¸V³¾ªº¨È«¬ (e.g. H1N7¡AH4N6) ¥D­n¶c¨Æ¦a¦b½Þ¤º§ä¨ì (Brown 1997, Karasin 2000)¡C¤@ºØ¥X¦Û¸V³¾ªºH9N2¯f¬r¦b¤¤°êªF³¡ªº½Þ¸s¤¤¤@¯ë¦a²±¦æþÓ (Xu 2004)¡C°£½Þ¤§¥~¡A®ü¬v­÷¨ÅÃþ°Êª«¤Î°¨³QÃÒ¹ê·|¥Ñ¸V³¾·½ÀY¨ú±o¥Ò«¬¬y·P¯f¬r (Guo 1992, Ito 1999)¡C

´¿¸g¦³´y­zÃö©ó®õ°ê°Êª«¶éªº¦Ñªê¤Î¨ä¥L¤j«¬¿ß¬ì°Êª«¡A³QÁý¥H¯f¬r§e¶§©ÊªºÂû«ÍÅé«á¡A¦ÛµM¦a·P¬VH5N1 (Keawcharoen 2004, Quirk 2004, Amosin 2005)¡C¾Ö¦³°ª¦º¤`²vªºÄY­«¯e¯f¦]¦Ó±µ¿æ¦Ó ¨Ó¡C¦Ó¥B¡A¿ß¬ì°Êª«¶¡ªº¶Ç¼½ÅãµMµo¥Í©ó¦P¤@¶¡°Êª«¶é (Thanawongnuwech 2005)¡C³o¬O²Ä¤@©v¿ß¬ì°Êª«·P¬V¬y·Pªº­Ó®×¡C®a®xªº¼Ú¬wµu¤ò¿ß¯à¦b¹êÅ礤·P¬VH5N1¯f¬r (Kuiken 2004)¡C

2004¦~¡A¥Ñ¦b¶V«n¦Û¥Ñº©¹Cªº½ÞÀò¨úªº3000­Ó¦å²M¼Ë¥»¥Î¨Ó¶i¦æ¦å²M¾Çªº´ú¸Õ¡A·j´M¬O§_¦³¨ü¬V©óH5N1¬y·P¯f¬r (Choi 2005)¡C¯f ¬r¤¤©MÀËÅç¤Î¦è¤èÂàº{¤ÀªR½T»{¤F¥u¦³0.25%ªº¼Ë¥»¬O§e¦å²M¤ÏÀ³¶§©Êªº¡C¦b¹êÅç©Ê·P¬V¡AÃÒ¹ê½Þ¯à³Q¹jÂ÷¦Û2004¦~¨È¬w¤HÃþ¤Î¸V³¾·½ÀYªºH5N1¯f¬r·P¬V¡C»´·L«y¹Â¤ÎÅé·Å¤W¤É¬O¦b·P¬V«á4¤é¤ºÆ[¹î¨ìªº¶È¦³¯f¼x¡C¯f¬r¥i¦b³Ì¤Ö6¤é¤º¹jÂ÷¦Û¤W©I§l¹D²Õ´¡C»ó«ø¤l²G¦b·P¬V«á2¤é±o¥X³Ì°ª¯f¬rºw©w«×¡A¦ý¨S¦³¹êÅç©Ê·P¬Vªº°Êª«±N¶Ç¬V¦Ü±µÄ²ªº½Þ°¦¡C¦b¨È¬w¬y¦æªº°ª«×­P©RH5N1¯f¬r¬Ý¨Ó¥i¥H¦ÛµM¦a·P¬V½Þ°¦¡CµM¦Ó¡A¨º¼Ëªº·P¬Vªºµo¥Í²vÅãµM¦a§C¡C¨S¦³³Q´ú¸Õªº¸V³¾¤Î¤HÃþH5N1¯f¬r¯à®e©ö¦a¦b¹êÅçÀô¹Ò¤Uªº½Þ°¦¶¡¶Ç¼½ (Choi 2005)¡C°ò©ó³o¨ÇÆ[¹î¡A½Þ°¦²{¦b¤j·§¤£·|¹ïH5N1¨È¬w¥@¨tªº¬y¦æ¯f¾Ç°_¤@­Ó­«­nªº§@¥Î¡C

2003¦~¬K¦b²üÄõ¡B¤ñ§Q®É¤Î¼w°êªº®a¸V¤¤¡Aµo¥Í°ª­P¯f©ÊH7N7¸V¬y·PªºÃzµo¡A¤Þ°_89­Ó¼ÉÅS©ó¨ü·P¬V°Êª«¤Î«ÍÅ骺®a¸V­û¤u¡A²£¥Í·P¬V¤Î»´·Lªº¯e¯f¡A¤j³¡¤ÀÄݵ²½¤ª¢ (Koopmans 2004)¡C¤@Ã~Â媺·P¬V¾É­P«æ©Ê©I§l§xÃøªº¯gª¬¡AÅܦ¨¦V­P©Rªº¤è¦Vµo®i (Fouchier 2004)¡C¦¹¥~¡A²üÄõÃzµo®É¡A¦b¯f¬r¾Ç¤Î¦å²M¾Ç¤W½T»{¤F¤@¨Ç®a®xªºH7N7·P¬V¡A¨ä¤¤¥|­ÓÅã¥Ü¦³µ²½¤ª¢ (Du Ryvan Beest Holle 2005)¡C¦b·N¤j§Q¤Î¤é¥»¡A¦³ÃÒ¾ÚÅã¥Ü¦b¨ä¥L±¡ªp¤U¦³¤HÃþ¨ü¨ìH9¡AH5¡AH7¨È«¬ªº§C­P¯f©Ê¸V¬y·P¯f¬r«~ºØªºµL¯gª¬¦ÛµM·P¬V (Zhou 1996, Puzelli 2005, Promed 20060110.0090)¡C

¦b¤@¶c¨Æ³ø§i (Promed Mail 20050826)¡A´£¤Î¥X¥Í©ó¶V«n°ê®a¤½¶é¥}¸Tªº¤T°¦¨u¦³ªG¤l¯W(Åe¿ß)¥Ñ©óH5N1¬y·Pªº­P©R·P¬V¡C·P¬Vªº·½ÀY¤´ÄÝ¥¼©ú½T¡C¦í¦b¾FªñÅ¢¤¤ªº¥t¥~20°¦¦PºØªG¤l¯W¡A«h¨S¦³¬V¯f¡C

¸V¬y·P¯f¬r±q¨S¦³¦b¦Ñ¹«¡B¥Õ¨ß¤Î¨ä¥L¦b­»´ä¬¡³¶³¾¥«³õ¤¤¦s¦bªº¤£¦P­÷¨ÅÃþ°Êª«¤¤µo²{¡A¦Ó¦b³o¨Ç¥«³õ´N¦³20%ªºÂû°¦¹ïH5N1¨È¬w¥@¨t§e¶§©Ê (Shortridge 1998)¡C

 

¬y¦æ¯f¾Ç

®a¸V

ª½¦Ü2003¦~¥½¡A°ª­P¯f©Ê¸V¬y·P³£³Qµø¬°®a¸V¨u¨£ªº¯e¯f¡C±q1959¦~°_¡A¥þ¥@¬É¥u¦³24©v°ò¥»ªºÃzµo (ªí¤@)¡C¦h¼Æ³£¬Oµo¥Í©ó¼Ú¬w¤Î¬ü¬w¡C¤j³¡¤ÀªºÃzµo³£¨ü¨ì¦a²z¤Wªº­­¨î¡A¥u¦³5©v¾É­PÅãµÛªº½¯©µ¦Ü²³¦hªº¹A³õ¡A¦Ó¥u¦³1©v¦b°ê»Ú¤W½¯©µ¡C¨S¦³¤@¦¸Ãzµo´¿¸g¹F¨ì2004¦~H5N1¨È¬wÃzµoªº³W¼Ò (WHO 2004/03/02)¡C®Ú¾Ú¬ö¿ý¡A©Ò¦³°ª­P¯f«¬ªºÃzµo³£¬O¥ÑH5¤ÎH7¨È«¬ªº¥Ò«¬¬y·P¯f¬r¤Þ°_¡C

¦b¹L¥hªºÃzµo¤¤¡A¨ü·P¬V¬¡³¾©Î¨ä¥¼¸g³B²z»s«~ªº«Dªk¥æ©ö©Î²¾°Ê¡A¥H¤Î³q¹L¤HÃþ²¾°Ê (®È«È¡AÃø¥Áµ¥) ªº¯f¬rªº«D¬G·Nªºª«²z¶Ç»¼¡A³£¬O¶Ç¼½°ª­P¯f©Ê¸V¬y·P¯f¬rªº¥D­n¦]¯À¡C

°ª­P¯f©Ê¸V¬y·PÃzµoªº·s³W¼Ò¦b2003¦~¥½Åܱo©úÅã¡C±q2003¦~12¤ë¤¤¨ì2004¦~2¤ëªì¡A¦bÁú°ê¡B¶V«n¡B¤é¥»¡B®õ°ê¡B¬Z®H¹ë¡B¦Ñ¾â¡B¦L¥§¤Î¤¤°ê§¡«ü¥X¡A¦³¥Ñ°ª­P¯f©Ê¸V¬y·P¨È¬w¥@¨tH5N1¯f¬r¦b®a¸V¤Þ°_ªºÃzµo¡C®a¸Vªº°ª­P¯f©ÊH5N1¬y·Pªº¼sªx¬y¦æ¦b¤£¦P°ê®a¦P®É¥X²{¬O¥vµL«e¨Òªº¡C©Ò¦³¥H²o¨î³o¯e¯f¬°¥Ø¼Ðªº§V¤O¨ì¥Ø«e¬°¤î³£¬O¥¢±Ñªº¡C¤£ºÞ1.5»õ°¦³¾Ãþªº®_±þ¤Î³Q±j¨î·´·À¡AH5N1¦b¦L¥§¤Î¶V«nªº«Ü¦h¦a°Ï¡A¥H¤Î¬Z®H¹ë¡B¤¤°ê¡B®õ°ê©M¤]³\¦Ñ¾âªº¤@¨Ç¦a°Ï¡A²{¥¿³Qµø¬°¦a¤è©Ê¯e¯f¡C

¥»¨Óªº¯f¬r¡A¦b1997¦~­º¦¸¹J¨ì¡A¬O¥X¦Û­«·s±Æ¦C²Õ¦X¨Ó·½ªº¡A¥]¬A³Ì¤Ö¤@ºØ®a®xÃZªºH5N1¯f¬r (A/goose/Guangdong/1/96¡A¥I¥XHA) ¤Î¤@ºØ¤j·§¨Ó¦ÛµuÀV³¥ÀnªºH6N1¯f¬r (A/teal/Hong Kong/W312/97¡A¥I¥XNA¤Î§@¬°¤º³J¥Õªº¤À¸`)¡C³o¯f¬r¸g¾ú§ó¦h§ó¦h»P¨ä¥L¥¼ª¾¸V¬y·P¯f¬rªº­«±Æ¶g´Á (Xu 1999, Hoffmann 2000, Guan 2002b)¡C²{¤w¦³H5N1¥@¨t¼Æ­Ó¤£¦P°ò¦]«¬ªº´y­z (Cauthen 2000, Guan 2002a+2003)¡C©Ò¿×ªº°ò¦]«¬¡uZ¡v¦Û2003¦~12¤ë¶}©lªºÃzµo¤¤¦û¤F­«­nªº¦a¦ì (Li 2004)¡C

µM¦Ó2005¦~4¤ë¡A¹F¨ì¤F¥t¤@­Ó°Êª«¬y¦æ¯fªºµ{«×¡C³o®É¡A¬O²Ä¤@¦¸¡AH5N1«~ºØ¯à°÷¤j¶q¦a±µÄ²¨ì³¥³¾¸s (Chen 2005, Liu 2005)¡C¦b¤¤°ê¦è¥_³¡ªº«C®ü´ò¡A¼Æ¤d°¦´³ÀY¶­¡A¤@ºØ¾E±pºØÄÝ¡A¦]¨ü·P¬V¦Ó¦º¤`¡C¼Æ­ÓÅäÎù·õ¬«~ºØ¤]¦b³o¦a°Ï¨ü¨ì¼vÅT¡C¦b2005¦~®L©u¤Î¬î©uªì¡A­º¦¸¦b¦a²z¦ì¸m¾Fªñªº»X¥j¡B«¢ÂħJ¤Î«n¦è§B§Q¨È¥X²{H5N1Ãzµo¡AÃhºÃ¯f¬r¬O¥Ñ¾E±p³¾Ãþ¶Ç¼½¡C2005¦~¥½¡A¥Ñ¤¤¨È¨ì¤¤ªF¤Î«D¬wªº­«Å|ªº­Ô³¾¾E±p³~®|¤W¤Î¤§¶¡¡A¨Ï¤g¦Õ¨ä¡Bù°¨¥§¨È¡B§Jù®J¦è¨È¦@©M°ê¤Î§J¨½¦Ì¨È¥b®q¾D¨ü¨ì¥t¥~ªºÃzµo¡C¦b©Ò¦³¨Ò¤l (°£¤F¦b»X¥j¤Î§Jù®J¦è¨È¦@©M°êªº) ¤¤¡Aµo²{®a¸V¤Î³¥¥Í¤ô³¾¨âªÌ³£¨ü¨ì¼vÅT¡C³q±`®a¸Vªº«ü¼Ð­Ó®×³£¦ü¥G¾Fªñ¦³³¥¥Í¤ô³¾´Ï®§ªº´ò¤ÎÀã¦a¡CÁöµM³o¬Ý¦ü´£¥X¤@­Ó¾E±p¤ô³¾¶Ç¼½¯f¬rªºª½±µ·t¥Ü¡A¦ý§Ú­ÌÀ³²M·¡ª`·N¨ì¥Ø«e¬°¤î°ª­P¯f©Ê¸V¬y·P¨È¬w¥@¨tH5N1¯f¬r¥u¯à±q««¦º©Î¦º¤`ªº³¥¥Í¤ô³¾¤¤ÀË´ú¥X¡C³¥¥Í¤ô³¾¸s¤ºªºH5N1¯u¥¿±¡ªp¤Î¨ä¦b¶Ç¼½¤¤©Ò¾á¥ôªº¨¤¦â¤´µM¬O¦pÁ¼¤@¯ë¡C¥Ø«e¡A¥u¯à±ÀÂ_³¥¥Í¤ô³¾¯à§_¦b¼ç¥ñ´Á®É±aþÓ¯f¬r¨ì«Ü»·ªº¶ZÂ÷¡A©ÎªÌ¬Y¨ÇºØÄݾ¨ºÞ¨üH5N1·P¬V¤´½T¹ê¯à«O«ù¥i°Ê¡C

µM¦Ó¡A¦b³o¨ä¶¡¡A¤¤°êªº¬ã¨s´¦ÅS¥X³Â³¶¤¤¦s¦bþÓ§ó¦h¨È¬w¥@¨tH5N1¯f¬rªº·s°ò¦]«¬ (Kou 2005)¡C¹jÂ÷¥X¯f¬rªº³Â³¶¤Î¹êÅ礤·P¬V³o¨Ç¯f¬rªºÀn¡A¨âªÌ³£¨S¦³ªí²{¥X¥ô¦ó¯f¼x¡C¦ý®É¡A¦b¶Ç¦ÜÂû°¦«á¡A«h¾É­P¥þ²±ªº°ª­P¯f©Ê¸V¬y·P¡C¥Ñ©ó¦P¤@¸V¸s¤J­±¤£¦Pªº³Â³¶±aþӼƭӥi°Ï§O¥Xªº°ò¦]«¬¡A¦Ó³o«Ü¥i¯à¬O¥Ñ¤£¦P¥¼ª¾¥X³Bªº¸V¬y·P¯f¬r­«±Æ§Î¦¨¡A¦]¦¹¥O¤HÃhºÃÃþ¦üH5N1ªº¯f¬r¦b­Y¤zªº®É¶¡(¤ë¥÷?)«e¤w¸g¶Ç¦Ü³o¨Ç³¶³¾¡C³o¨Ç¸ê®Æªí¥Ü¥X¥t¤@­Ó´c¤Æªº¨BÆJ: ³Â³¶¡A°ò©ó¨e­Ìªº´Ï®§²ßºD¡A¬O³¥¥Í³¶³¾¤Î®a¸Vªº²z·Q¤¤¤¶ªÌ¡A¥H¤Î¥i¯à±N°ª­P¯f©Ê¸V¬y·P¯f¬r¦b³o¨Ç±Ú¸s¶¡¶Ç°e¡C¦b®õ°ê¤Î­»´ä¥ç«ü¥X¦³¦a°Ï©Ê­­¨î¦a·P¬V°ª­P¯f©ÊH5N1ªº­Ó§O (±w¯f©Î¦º¤`) ³Â³¶¡C»P¤HÃþ©w©~¦a¦³ºò±KÁpô¦a¥Í¬¡ªº¿P³¶Ãþ³¶³¾¡A¦p³Â³¶¡B¼Ú±°³¾¤Î¿P¤l¡A¨e­Ì¤ºªº°ª­P¯f©Ê¸V¬y·P¯f¬rªº¦a°Ï©Ê¡A¤£¶È¹ï·í¦aªº®a¸V·~ºc¦¨­«¤jªºÀ£¤O¡A¦Ó¥B¼W¥[¤HÃþ¼ÉÅS©ó¯f¬rªº­·ÀI (Nestorowicz 1987)¡C

 

¤HÃþ

ºI¦Ü2005¦~12¤ë30¤é¡AH5N1¤HÃþ­Ó®×¤w¦³142©v¡C¤HÃþªº¬y¦æ©Ê²{¥u­­©ó¬Z®H¹ë¡B¦L¥§¡B®õ°ê¥H¤Î¶V«nªº¶°¤¤ÂI(­Ó®×¤¤ªº65.5%)¡C72¤H (50.7%) ¤w¦]¦¹¦º¤`¡C

¦Ü©ó§ó¸ÔºÉªº¸ê®Æ¡A¥i°Ñ¦ÒÃD¥Ø¬°¡u¬y¦æ¯f¾Ç¡v(Epidemiology) ªº¤@³¹¡C

 

¸gÀÙ¤Wªº«áªG

°ª­P¯f©Ê¸V¬y·PªºÃzµo¹ï³æ¤@¹A¤Ò¤Î¨ü¼vÅT¦a°Ïªº®a¸V·~¥i»¡¬O´dºGªº (¨£ªí¤@)¡C¸gÀÙ·l¥¢³q±`¥Ñ©ó®a¸V¦]°ª­P¯f©Ê¸V¬y·Pªº·P¬Vªºª½±µ¦º¤`¥u¬O¨ä¤¤¤@³¡¤À¡C¥Î¨Ó¹w¨¾¯e¯f¶i¤@¨BÂX´²ªº±¹¬I¾É­P¤F­«¤jªº·l¥¢¡CÀç¾i·l¥¢¹ïµo®i¤¤°ê®a¨Ó»¡¦P¼Ë¤]¬OÅå¤Hªº¡A¦]¬°®a¸V¬O¥L­Ì¥D­nªº°Êª«³J¥Õ½è¨Ó·½¡C·íÃzµoÅܱo¼sªx«á¡A´N«ÜÃø±±¨î¡A¦Ó¥B¥i¯à»Ý®É¦h¦~ (WHO 2004/01/22)¡C

 

¹ï§Ü°ª­P¯f©Ê¸V¬y·Pªº±±¨î±¹¬I

¥Ñ©ó°ª­P¯f©Ê¸V¬y·P¹ï¸gÀÙªº¼ç¦b¯}Ãa©Ê½ÄÀ»¡A¥¦¦b¥þ¥@¬É¨ü¨ìĵ±§¦aªººÊºÞ¤ÎÄY®æªºªk³W©ÒºÞ¨î (Pearson 2003, OIE Terrestrial Animal Health Code 2005)¡C¹ï§Ü°ª­P¯f©Ê¸V¬yªº±¹¬Iµø¨ü¼vÅT¦a°Ïªº¬y¦æ¯f¾Ç§Î¶Õ¦Ó©w¡C¦b¼Ú·ù¡A°ª­P¯f©Ê¸V¬y·P¨Ã¤£ÄÝ©ó¦a¤è¯f¡A´¶¹M¬O¸T¤î¨Ï¥Î¸V¬y·Pªº¹w¨¾©Ê¬Ì­]ªº¡C¦]¦¹¡A¥Ñ©óÅå¤HªºÁ{§É¹Lµ{¡A®a¸V¤¤Ãzµo°ª­P¯f©Ê¸V¬y¬O¹w´Á¤¤ÅãµÛ¡Cµ²ªG¡A­±¹ï¨º¼ËªºÃzµo¡A´N­n¹ê¦æ¶i¨úªº±±¨î±¹¬I¡A¦p¼³·À¨ü·P¬V¤Î»P¨ä¾Fªñªº«O¦³¦a¡A¥Øªº¬O¬°¤F¥ß¨è®ø·À°ª­P¯f©Ê¸V¬y·P¯f¬r¤Î±NÃzµoºû«ù¦b¦³¸ñ¶Hªº«O¦³¦a½d³ò¤º¡C

¬°¤F³o¨Ç¥Øªº¡A±±¨î¤ÎºÊµø°Ï°ì·|«Ø¥ß¦b¦³¸ñ¶H¦a°ìªº©P³ò¡Aª½®|µø°ê®a¦Ó©w (¦b¼Ú·ù¡A¤À§O¬O3¦Ü10¤½¨½)¡C¨ü·P¬V¤Î¾Fªñªº¹A³õªº¹jÂ÷¡A§Ö³t±þ¦º©Ò¦³¨ü·P¬V¤Î¼ÉÅSªº³¶³¾¡A¥H¤Î§´µ½±ó¸m°Êª««ÍÅé¡A³£¬O¹w¨¾¹ï¨ä¥L¹A³õ°¼¦V¶Ç¼½ªº¼Ð·Ç±±¨î±¹¬I (OIE . Terrestrial Animal Health Code)¡C¦bÃzµo´Á¶¡¡A¬¡®a¸V¤Î®a¸V»s«~¦b°ê¤º¥~ªº²¾°Ê­­¨î¬O¤Q¤À­«­nªº¡C

¦¹¥~¡A§Q¥Î´ú¸Õ¤Î­ç°£«æ©Ê¦Ã¬Vªº«O¦³¦a¨Ó§@®a¸V§C­P¯f©Ê¸V¬y·PH5¤ÎH7¨È«¬ªº±±¨î¡A¥Øªº¦b©ó´î§C°ª­P¯f©Ê¸V¬y·P¯f¬r±q¨º¨Ç«O¦³¦a­«·s¥Íªøªº­·ÀI¡A³o¹ï«D¦a¤è¯fªº¦a°Ï©Î³\¬O«ê·íªº¡C

³o®Ú°£Æ[©Àªº¯S¦³°ÝÃD¥i¯à·|¦b: (i) °ª±K«×®a¸V±Ú¸s (Marangon 2004, Stegemann 2004, Mannelli 2005) ¤Î (ii) ²±¦æ¤p«¬¨p¤H«O¤H¦a§@®a¸V¦Û¥Ñº©¹C (Witt and Malone 2005) ªº¦a°Ï²£¥Í¡C¥Ñ©ó®a¸V«O¦³¦aªººò±K¾F±µ¤Î¨ä¤u·~ªºªÈÄñºc³y¡A¯e¯fªº¶Ç¼½³t«×¤ñ®ø°£±¹¬I§Ö¡C¦]¦¹¡A¦b1999/2000¦~ªº·N¤j§QÃzµo´Á¶¡¡A¤£¶È¨ü·P¬V¤Î¾Fªñªº«O¦³¦a¨ü¯}Ãa¡A¦b¨ü¦Ã¬V¹A³õªº¥b®|1¤½¨½¤º¦³·P¬V­·ÀIªº¸V¸s¤]±j¨î©Ê³Q±þ¡C¤£¹L¡A®Ú°£¤u§@»Ý®É¥|­Ó¤ë¡A¦Ó¥B­n¦³¤@¤d¤T¦Ê¸U°¦³¶³¾¦º¤` (Capua 2003)¡C³ò¶¨ü¦Ã¬V¹A³õ¤@¦Ü¼Æ¤½¨½«Ø¥ß§¹¥þ¨S¦³¥ô¦ó®a¸Vªº½w½Ä¦a±a¥ç¬O2003¦~²üÄõ¤Î2004¦~¥[®³¤j¦¨¥\®ø°£°ª­P¯f©Ê¸V¬y·P¯f¬rªº­ì¦]¡C©Ò¥H¡A¤£¥u¬O¯e¯f¥»¨­¡A¦Ó¥BÁÙ¦³°Êª«ªº±j¨î©Ê®_±þ¡A¾É­P¤À§O¤T¤d¸U¤Î¤@¤d¤E¦Ê¸U³¶³¾ªº®½¥¢¡C1997¦~¡A­»´ä·í§½¦b¤T¤é¤º (12¤ë29¡A30¤Î31¤é) ®_±þ¤F©Ò¦³®a¸V (¤@¦Ê¤­¤Q¸U°¦³¾Ãþ)¡C¤W­z±¹¬IªºÀ³¥Î¡A¦®¦b¥ß¨è®ø°£°ª­P¯f©Ê¸V¬y·P¯f¬r¦Ó¥H±þ¦º¨S¨ü·P¬Vªº³¶³¾¬°¥N»ù¡A³o¹ï°Ó·~¹A³õ¤Î«°¥«¦a°Ï¨Ó»¡©Î³\¥i¦æ¡CµM¦Ó¡A³o·|¹ï®a¸V·~±a¨Ó­«¤jªºµh­W¡A¥H¤Î¿E°_¤½²³¹ï©ó®_±þ½w½Ä¦a±a¤º¼Æ¥H¦Ê¸U­p°·±d¤Î¨S¨ü·P¬V°Êª«ªº¹D¼w§Q®`Ãö«Y¡C

³oÃþ±¹¬I¡A¦b¥H¶Ç²Î¤è¦¡¹}¾i®a¸V (ÂûÀn¯à¦Û¥Ñº©¹C¡A»P³¥¥Í³¶³¾²V¦X°_¨Ó©Î¦@¦P¤À¨É¤ô·½) ªº¹A§ø¦a°Ï¡A¬O³ÌÃø¹ê¦æªº¡C¦¹¥~¡A®aÀn·|§l¤Þ³¥Àn¡A´£¨Ñ³¥³¾¤Î®a¸V¶¡¶Ç¼½ªº¤@­Ó­«­nÁpô (WHO 2005)¡C³o¨Ç±¡ªp©Î·|´£¨Ñ°ª­P¯f©Ê¸V¬y·P¯f¬rÀò±o¦a¤è©Êª¬ºAªº°ò¦¡C

¦b¬Y¦a°Ïªº°ª­P©Ê¸V¬y·P¦a¤è©Ê·|µ¹®a¸V«O¦³¦a±a¨Ó«ùÄòªºÀ£¤O¡C¥Ñ©ó¤W­zªº­­¨î¤£¯à¦b¨S¦³¹ï°ê®aªº®a¸V·~³y¦¨­«¤j·l®`¡A©Î¨S¦³¹ïµo®i¤¤°ê®a¤Þ°_ÄY­«ªº³J¥Õ½è¨ÑÀ³µu¯Êªº±¡ªp¤Uªø®É¶¡ºû«ù¡A©Ò¥H¤@©w­n¦Ò¼{¨ä¥Lªº±¹¬I¡C

¦b³o¨Ç±¡ªp¤U¡A±µºØ¬O³Q¼sªx¦a¨Ï¥Î¡A¦Ó¥B©Î³\¯à§@¬°«D¦a¤è¯f¦a°ÏªºÃzµoªº®Ú°£¹Lµ{¤¤ªºªþ§U¤â¬q¡C

 

±µºØ

¦bÃ~Â媺¥@¬É±µºØ¬O¦b°l¨D¥|­Ó¥Ø¼Ð: (i) Á{§É¯e¯fªº¨¾Å@; (ii) ¦³¬r¯f¬r·P¬Vªº¨¾Å@; (iii) ¯f¬r¤Àªcª«ªº¨¾Å@¤Î (iv) ±µºØ°Êª«·P¬Vªº¦å²M¾Ç°Ï§O (serological differentiation of infected from vaccinated animals; §Y©Ò¿×ªºDIVA­ì²z)¡C

¬y·P±µºØªº»â°ì¤º¡A¤£½×°Ó·~¤W¥i¥Îªº©Î¹êÅç¤W´ú¸Õªº¬Ì­]¨ì¥Ø«e¬°¤î³£¨S¦³¯à²Å¦X¥þ³¡³o¨Ç­n¨Dªº (Lee and Suarez 2005)¡C²Ä¤@­Ó¥Ø¼Ð¡A§Y¨¾Å@¥Ñ°ª­P¯f©Ê¸V¬y·P¯f¬r¤Þ°_ªºÁ{§É¯e¯f¡A¤j³¡¤Àªº¬Ì­]³£¥i¹F¨ì¡C¬Ì­]±µºØªÌ·P¬V¦³¬r¯f¬r¤Î¨ä¤Àªcª«ªº­·ÀI³q±`³£³Q­°§C¡A¦ý¤£¯à§¹¥þ¨¾¤î¡C³o©Î·|¦b¹ê¦æ¹ý©³±µºØªº¦a¤è¯f¦a°Ï¾É­P­«¤jªº¬y¦æ¯f¾Ç°ÝÃD: ¬Ý¨Ó°·±dªº¤w±µºØ³¶³¾¥i¯à¤w¥R¤À¦a¨ü·P¬V¡A¦b¬Ì­]ªº±»Å@¤U¤Àªc¥X¯f¬r¡C¦³®Ä­°§C¯f¬r¤Àªc¹ï±±¨î±¹¬I (§Y¦³¬r¯f¬rªº®ø°£) ªº¥D­n¥Ø¼Ð¨Ó»¡¬O¤Q¤À­«­nªº¡C¨ä®Ä²v¥i¥H¥Ñ½Æ»s¦]¤lr0¶q¤Æ¡C°²³]¤@±µºØ¤Î¨ü·P¬Vªº¸V¸s¥­§¡±N¶Ç¬V¯f¶Ç¦Ü¤Ö©ó¥t¤@­Ó¸V¸s (r0<1)¡A¦b¼Æ¾Ç¥ß³õ¤W¡A¦³¬r¯f¬r¬O¶É¦V®ø¥¢ªº (van der Goot 2005)¡C¦b³B²z¹ï§Ü¼ç¦b©Ê°Êª«¶Ç¼½ªºH5N1¯f¬rªº±µºØ®É¡A­°§C¯f¬r¤Àªc¤]·|´î§C¶Ç¬V¤HÃþªº­·ÀI¡A¦]¬°¦ü¥G»Ý­n­«¤jªº¯f¬r¾¯¶q¨Ó¬ï¹L³¾Ãþ»P¤HÃþ¶¡ªººØÃþ«Ì»Ù¡C³Ì«á¡A¦ý¨Ã«D¤£­«­nªº¬O¡ADIVA§Þ³N¥ç®e³\¦b¤w±µºØ³¾Ãþ¥H¦å²M¾Çªº¤èªk°l¬d¯f¬r·P¬V¡C

§@¬°¹ê»ÚªºÀ³¥Î¡A¤@©w­n¿í¦u¼Æ­Ó±ø¥ó (Lee and Suarez 2005):

a) ¥Ñ©ó·|¦³°ò¦]­«±Æªº¥i¯à©Ê¡A¥H¤ÎH5¤ÎH7¨È«¬¦ÛµM¬ðÅܦӼW¥[­P¯f©Êªº­·ÀI¡A¬Ì­]¤£¥i¥H¥Ñ¦³½Æ»s¯à¤Oªº¬y·P¯f¬r²Õ¦¨¡C©Ò¥H¡A¬¡©Ê´î¬r¬Ì­]¤w³Q²^¨O¡C

b) ¹ï®a¸Vªº°ª­P¯f©Ê¸V¬y·P¨¾Å@¥D­n¨Ì¿à¹ïHA¦³¯S²§©Êªº§ÜÅé¡C¦]¦¹¡A¬Ì­]¯f¬rÀ³»P²{³õ¯f¬rÄݦP¤@H¨È«¬¡C²z·Q¦a¬Ì­]¯f¬r»P²{³õ¯f¬rªº§¹¥þ§k¦X¡A¦p¦P¨Ï¥Î©ó¤HÃþªº¬Ì­]ªº­n¨D¡A¦b®a¸V¤¤«h¤£¬O±j¨îªº¡C¥Ñ©ó¨S¦³¼sªxªº±µºØ¡A²{¯Ê¥F¸V¬y·P¯f¬r¤º¥Ñ¬Ì­]ÅX°Êªº§Ü­ìÄƲ¾¡A¦b®a¸V¤¤»¤µo¦P«¬¥æ¤e¤ÏÀ³ªº§K¬Ì¤O©Î³\¤w¨¬°÷¥Î§@¨¾Å@¡C

c) À³¨Ï¥Î¼Ð°O (DIVA) ªºµ¦²¤ (Suarez 2005)¡C§@¬°¿ï¾Ü¡A©Î¥i¨Ï¥Î­ï§L³¶³¾¨Ó§@ºÊ±±¡C

²{¦b¤wµo®i¥X¤@¤j°ïªº¬Ì­]·§©À¡C¤j³¡¤À¤´µM¥H¥¢¬¡¤Î»²§U©Êªº§¹¾ã¯f¬r¬Ì­]¬°°ò¦¡A¦ÓÀ³¥Î®É»Ý­n¤À§O¹ï¨C°¦°Êª«¨Ï¥Î°w¤Îª`®g¾¹¡C

°ò©ó¹ê»Ú°ª­P¯f©Ê¸V¬y·P«~ºØªº¥¢¬¡¤Æ¦P«¬¬Ì­]¡A·|¤Þ°_¾A·íªº«OÅ@§@¥Î¡A¦ý¤£®e³\¦å²M¾Ç¤W¤À¿ë¬Ì­]±µºØªÌ¤Î¨ü·P¬V³¾Ãþ¡C¥Ñ©ó¬Ì­]¬O¥Ñ²{®Éªº°ª­P¯f©Ê¸V¬y·P¯f¬r»s¦¨¡A¦b¬Ì­]¹ê»ÚÀ³¥Î®É¡A·|¦³©T¦³ªº©µ»~¡C

¬Û¤Ï¡A¥¢¬¡¤Æ²§«¬¬Ì­]¡A·í¬Ì­]¯f¬rªí¹F¥X»P²{³õ¯f¬r¬Û¦PªºHA¨È«¬¦ý¤£¦PªºNA¨È«¬®É¡A¥i¥H¥Î§@¼Ð°O¬Ì­] (e.g. H5N9¬Ì­]¹ïH5N2°ª­P¯f©Ê¸V¬y·P)¡C§Q¥ÎNA¨È«¬¯S²§§ÜÅ骺´ú©w¡A¯à°÷¤À¿ë¥X¬Ì­]±µºØªÌ¤Î¨ü·P¬V³¾Ãþ (Cattoli 2003)¡CµM¦Ó¡A³o¨Ç¤èªk¬O¬Û·í¦Y¤O¦Ó¥B©Î·|¯Ê¥F±Ó·P©Ê¡CÁöµM¦p¦¹¡A¦¹Ãþ¬Ì­]¥i¥H¦s©ñ¦b¥Ñ¼ÆºØ¾Ö¦³¤£¤@­PNA¨È«¬ªºH5¤ÎH7¨È«¬ºc¦¨ªº¬Ì­]®w¡C¤Ï¦V¿ò¶Ç¾Ç¤j¤j¦a¦³§U©ó»s³y¬°Ã~Âå¤ÎÂåÀø¥Î³~¨âªÌ¨Ï¥Î¡A¦Ó»Ý¨DªºHxNy²Õ¦X¦b¾A¦X¿ò¶Ç­I´º¤ºªº¬Ì­] (Liu 2003, Neumann 2003, Subbarao 2003, Lee 2004, Chen 2005, Stech 2005)¡C²{®É¡A¥¢¬¡¤Æ²§«¬¬Ì­]¥¿¦bªF«n¨È¥H¤Î¾¥¦è­ô¡B¤Ú°ò´µ©Z¤Î¥_·N¤j§Qµ¥H5N1¼ç¦b¦MÀI¦a°Ï¹ê¦a¨Ï¥Î (e.g. Garcia 1998, Swayne 2001)¡CNS-1¯S²§§ÜÅ骺´ú©w³Q´£¥X§@¬°¥¢¬¡¤Æ¬Ì­]¨Ï¥Î¤W¥t¤@DIVA¨t²Îªº¿ï¾Ü (Tumpey 2005)¡C³o¨Ç§ÜÅé¦b°ªºw©w«×¤U¥Ñ¨ü·P¬V³¾Ãþ²£¥Í¡A¦ý·í¨Ï¥Î¥¢¬¡¤Æ¬Ì­]®É¡A·|¦b¬Û·í§Cºw©w«×¤U²£¥Í¡C

¬¡´C¤¶­«²Õ¬Ì­]¦b¯à°÷·P¬V®a¸Vªº¯f¬r©Î²Óµß°©·F¤¤ªí²{¥X H5 ©Î H7 NA°ò¦] (e.g. ¸Vµk¯f¬r [Beard 1991, Swayne 1997+2000c]¡A³ï®ðºÞª¢¯f¬r [Lueschow 2001, Veits 2003] ©Î·s«°Âû½E¯f¬r [Swayne 2003] )¡C¥Ñ©ó¬O¬¡¬Ì­]¡A³q¹L¤ô©Î¼QÃúªº¤j¶q¹B¥Î³q±`³£¬O¥i¦æªº¡CÁöµM¤¹³\©ú½TªºDIVA¿ëÃÑ¡AµM¦Ó¹ï´C¤¶¯f¬rªº¹w¥ý¦s¦bªº§K¬Ì¤O±N·|¤j¤j¦a§«Ãª±µºØªº¦¨¥\¡C¦b¾¥¦è­ô¤Î¬ü°ê¤w¦¬°¦¤F¤@¨Ç»P¸Vµk­«²ÕÅ馳Ãöªº¹ê¦a¸gÅç¡C

³Ì²×¡A¹êÅçÃÒ©ú¤F­«²Õªí²{ªºHA³J¥Õ¤Î¥ÎHAªí²{½èÅ骺DNA±µºØªº¦¨¥\¨Ï¥Î (Crawford 1999, Kodihalli 1997)¡C

ªF«n¨Èªº¼Æ­Ó°ê®a²{¥¿­p¹º¥H¥þ°ê©Êªº¤j³W¼Ò¦æ¨Ï±µºØ (Normile 2005)¡C

 

¯e¯f¥þ°ê¬y¦æªº­·ÀI

¥þ°ê¬y¦æ¯e¯fªºµo¥Í»Ý­n²Å¦X¤T­Ó±ø¥ó:

a) ¦Ü¤Ö¦b¤@­Ó¤HÃþ¥@¥N¨S³Q¹îıªº¬y·P¯f¬rHA¨È«¬¥X²{ (©Î¦A¥X²{) ©M

b) ¦b¤HÃþ¯à°÷¦³®Ä¦a¶Ç¬V¤Î½Æ»s ©M

c) ¦b¤HÃþ¶¡®e©ö¤Î«ùÄò¦a¶Ç¼½¡C

³oÅã¥Ü·s«¬¤HÃþ¬y·P¬y¦æ¯f«Â¯Ù¨Ã¤£¬O°ß¤@¦a»P°ª­P¯f©Ê¸V¬y·PH5N1ªº¥X²{¦³Ãö¡C¨ì¥Ø«e¬°¤î¡AH5N1¥u²Å¦X³o¨Ç±ø¥óªº¨ä¤¤¨â­Ó: ¹ï«D±`¤j³¡¤Àªº¤HÃþ¤H¤f¨Ó»¡¡A¥¦¬O·sªº¨È«¬¡A¦Ó¥¦¨ì²{®É¬°¤î¤w·P¬V¶W¹L140¤H¡A¾É­PÄY­«ªº¯e¯f¤Î°ª­P©R©Ê¡C¦b«D±`¤j³¡¤Àªº¤HÃþ¤H¤f¤¤¨S¦³¹ïH5N1Ãþ¦ü¯f¬rªº§K¬Ì¯à¤O¡C­Y¨È¬w¥@¨tH5N1¡A³q¹L³v¨B¾AÀ³©Î»P¤w¾AÀ³¤HÃþªº¯f¬r­«²Õ¡A±q¦Ó¨ú±o¦³®Ä¤Î«ùÄò¦b¤HÃþ¶¡¶Ç¼½ªº¯S©Ê¡A§Ú­Ì±N·|­±Á{·s«¬¬y¦æ¯fªº¥X²{ (Guan 2004)¡C¦b¸ÕºÞ¤º¤wÃÒ©ú¡A¦b¨È¬w¥@¨t°ª­P¯f©Ê¸V¬y·PH5N1ªºHA³J¥Õªº¨üÅéµ²¦X¦ìÂI¤º¨âºØ®ò°ò»Äªº¦P®É¥æ´« (Q226L and G228S) ·|¨Ï»P2-6«¬ªº¤HÃþ¨üÅ骺µ²¦X³Ì¦³®Ä¦a¶i¦æ¡A¦p¨ä¥L¤w¾AÀ³¤HÃþªº¥Ò«¬¬y·P¯f¬r¤@¯ë (Harvey 2004)¡CGambaryan µ¥¤H (2006) ¸g¤wÃѧO¥X·½¦Û¤@¹ï2003¦~·P¬VH5N1ªº¤÷¤lªº¨â­Ó¤HÃþ¹jÂ÷ª«¡A¦Ó³o»P¨ä¥L©Ò¦³¨Ó¦Û¤HÃþ¤Î³¶³¾ªºH5N1¹jÂ÷ª«¬Û¤Ï¡AÅã¥Ü¥X¹ï2-6¨üÅ馳¸û°ªªº¿Ë©M¤O¡A³o¬O¥Ñ©ó¦bHA1¨üÅéµ²¦X¦ìÂI¤º¿W¯SªºS227N¬ðÅÜ¡C

³o¨Ò¤l¥i¯à¦b¾\Ū³o¤å³¹®É¥u¬O§Y±N¨ÓÁ{©ÎªÌ¤w¸gµo¥Í ¢w ¨S¦³¤H¥i¥Hª¾¹D©Î¹w¨¥¡C³oºØ¨Æ¥óµo¥Íªº¾÷·|¬Oª½±µ»P®a¸V¤º¶Ç¼½ªº¯f¬r¼Æ¶q¡A±q¦Ó»P¤HÃþ¼ÉÅS¨ä¤¤ªº­·ÀI¦³Ãö¡C©Ò¥H¡A¦bH5N1ªº®Ú·½»P¨ä·i°«¥ç¯à­°§C¯f¬r³y¦¨ªº¬y¦æ¯f­·ÀI¡C²§ºÝ¦a¡A¦b¤¬Ápºô¶l¥ó¤Î°Q½×°Ï¤w«Øij¡A¥u»Ý°Ê¥Î­p¹º§@¬°®ø°£®a¸V¤¤H5N¦Óµo®iH5¯S²§¤HÃþ¬Ì­]ªº¸êª÷ªº¦Ê¤À¤§¤Q¡A·|¤ñ¬°§K¤HÃþ¨üH5N1¬y¦æ¯f«Â¯Ù¦Ó¶i¦æ±µºØ¦³§ó¤jªº®ÄªG¡C

¦Û±qH5N1¦b1997¦~­º¦¸¥Ñ¤HÃþ¹jÂ÷¥X¨Ó¡A¥¦³£¤£¯à§¹¦¨¹ï¤HÃþ±J¥D²£¥Í¬y¦æ¯f³o³Ì«á¨BÆJ¡CµM¦Ó¡Aªñ´Áªº¬ã¨s´£¥X¡A¦b¼Æ¦~¶¡¡AH5N1¹ï­÷¨ÅÃþ°Êª«ªº¬r©Ê´£°ª¤F¡A¦Ó±J¥DªºÃþ§O¥çÂX¤j¤F:

1. 1999¦Ü2002¦~¹jÂ÷¦Û¤¤°ê¤º¦a¡A¥H¤Î±q2003¦~¹jÂ÷¦Û¶V«nªº©úÅã°·±dªº®aÀnªºH5N1¡A¤w¤éº¥Åܱo¹ï­÷¨ÅÃþ°Êª«¦³§ó°ªªº¬r©Ê (Chen 2004)¡C

2. H5N1¤wÂX¤j¤F¥¦ªº±J¥DÃþ§O¡A¦ÛµM¦a·P¬V¤Î±þ¦º¥H«e»{¬°¯à©è§Ü¸V¬y·P¯f¬r·P¬Vªº­÷¨ÅÃþ (¿ß¡A¦Ñªê) (http://www.who.int/csr/don/2004_02_20/en/ index.html)¡C

¦ý¬O¡A¦bª`µø¨È¬wH5N1±¡ªpªº¦P®É¡A¤£À³©¿²¤¨ä¥L¥i¯à¦³§ó¤j¾É­P¬y¦æ¯f¼ç¤Oªº¬y·P¯f¬r¦³¾÷·|¥X²{©Î¤w¸g¥X²{¡C¨Ò¦p¡A¦b1980¦~©Î¤§«e¦b¨È¬w§ä¤£¨ìªºH9N2¨È«¬«~ºØ¡A¦b¨È¬wªº®a¸V¸s¤¤¤£¦ý¤wÅܱo´¶¹M¡A¦Ó¥B¤w¦³®Ä¦a»P¤¤°êªF¤ÎªF«n³¡ªº½Þ¸s¥æÂø (Shortridge 1992, Peiris 2001, Xu 2004)¡C³o¨Ç¯f¬rªº¨üÅéÅã¥Ü¥XÃþ¦ü¾AÀ³¤HÃþªº¯f¬rªº¯S²§©Ê (Li 2005b, Matrosovich 2001)¡C³o¨ÇH9¯f¬r¦³«Ü¼sªxªº±J¥DÃþ§O¡A¦b°ò¦]¤è­±¬Û·í¦h¼Ë¤Æ¡A¥H¤Î¯àª½±µ·P¬V¤HÃþ¡CH9N2«~ºØ¡A§Y¾É­P¦b­»´ä³o¨Ç¤HÃþ·P¬V­Ó®×ªº­ì¦]¡A§óÅã¥Ü¥X»P1997¦~ªºH5N1¯f¬r¬Ûªñªº°ò¦]«¬ (Lin 2000)¡C

 

µ²½×

¦b¹L¥h¤Q¦~¡A°ª­P¯f©Ê¸V¬y·P (avian influenza, AI) §@¬°®a¸Vªº¯}Ãa©Ê¯e¯fªº­«­n©Ê¸g¤wÅãµÛ¦a¤W¤É¡C§C­P¯f«¬ (low pathogenicity, LP) H5¤ÎH7¨È«¬ªº¸V¬y·P¯f¬r¥Ñ³¥¥Í¤ô³¾Àx®wªº¶Ç¤J¬O³o­Ó¹Lµ{ªº°ò¦¡C²{¦b©|«Ý»¡©ú§C­P¯f«¬H5¤ÎH7¦b¨äÀx®w¤¤ªº²±¦æ¬O§_¥¿¦b§ïÅÜ¡A¥H¤Î¨ä§ïÅܪº¦]¥Ñ¡CÃö«Y¨ìªF«n¨È®a¸V¸sªº¨È¬w¥@¨t°ª­P¯f©Ê¸V¬y·PH5N1ªº¦a¤è©Êª¬ºA¦Ó¹ï¾E±p³¶³¾¸s¤Þ°_ÀWÁcªº·¸¥X¡A¹ï©ó¾E±p³¥³¾¸sªº¦a¤è©Ê¡A°ª­P¯f©Ê¸V¬y·P¬y¦æ¯f¾Çªº·§©ÀÂಾ¦ü¥G¤Q¤À¹G¤Á¡C³o·|¹ï¸ó¤j³°³W¼Òªº®a¸V·~¦³­«¤jªº¼vÅT¡C¤HÃþ¼ÉÅS©ó¯f¬rªº­·ÀI¬Oª½±µ»P®a¸V¤¤¼W¥[¼ç¦b©Ê°Êª«¤HÃþ¯f¬rªº¦s¦b¦³Ãö¡C

¯A¤Î¨ì³¾Ãþ¤ÎÃ~Âå¤è­±ªº±¡ªp¡A¦³«Ü¦h°ÝÃD¤´µM¥½³Q¸Ñµª:

1. ¦b³¥¥Í¤Î¾E±p³¾Ãþ¸s¤¤¡A¨È¬w¥@¨t°ª­P¯f©Ê¸V¬y·PH5N1¬O§_¤w«Ø¥ß¥X¬y¦æ¯fªºª¬ºA?

2. °ª­P¯f©Ê¸V¬y·P¯f¬r¯à§_¦b³¥³¾«~ºØ¶i¤Æ¦¨´î¬r¥Íª««¬¡A¦Ó«O¯d¹ï®a¸Vªº¬r©Ê?

3. ³°¦a°Êª«¬O§_¹ï°ª­P¯f©Ê¸V¬y·P¯f¬rªº¶Ç¼½¦³¨ä§@¥Î?

4. ¸Ñ½X§@HA³J¥Õªº¤º³J¥Õ°Å¤Á¦ìÂIªº§Ç¦C½d³ò¡A¬O§_¥u¦bH5¤ÎH7¨È«¬¶É¦V©ó¬ðÅÜ ?

5. ¦b¨È¬w¡A¬°¹ï§ÜH5N1ªº®a¸V¤j¶q±µºØªº¼vÅT±N·|«ç¼Ë? ¨¾¤î¯f¬rÂX´²©Î¬O¥[³t§Ü­ìÄƲ¾©Î°kÁ×?

6. §C­P¯f©Ê¸V¬y·P¨È«¬H5¤ÎH7¦b¤ÑµMÀx®wªº²±¦æªºÂಾ·|§_¤]¦³¥i¯à¼vÅT¨ì¶i¤Æ°±º¢ªº±¡ªp?

¯S§O¬O²Ä¤@­Ó°ÝÃD¡A¦³þÓÀ£­Ë©Êªº­«­n©Ê ¢w ¦Ó³o¨Ã¤£­­©óÃ~Âå¤è­±¡C¨È¬w¥@¨t°ª­P¯f©Ê¸V¬y·PH5N1¦b¾E±p³¾Ãþ¤¤ªº¦a¤è©Ê¡A·|µ¹®a¸V«O¦³¦a±a¨Ó«ùÄòªº«Â¯Ù¡Cªþ¦X³o­n¨DÀ³¥]¬A¦b®a¸V«O¦³¦a¸T¤î¦Û¥Ñº©¹Cµ¥ÄY®æªº¥Íª«¦w¥þ±¹¬I¹J¨ì¡C§@¬°¿ï¾Ü¡A¥ç­n¦Ò¼{®a¸Vªº¤j¶q±µºØ¡C§@¬°²Ä¤G­Ó³~®|¡A³¥¥Í³¶³¾ªº¦a¤è©Ê¡A©Î³\¤]¥i¾É­P°ª­P¯f©Ê¸V¬y·PH5N1¯f¬r¦b¦ÛµMÀô¹Ò (´ò¡A®ü©¤µ¥) ¤¤¦s¦b¡A¥H¤Î¥i¯à±a¨Ó¤HÃþ¼ÉÅS©ó¯f¬rªº¼ç¦b©ÊÃB¥~­·ÀI¡C¨ì¥Ø«e¬°¤î¡A¨S¦³³ø§iÅã¥Ü¦³±q³¥³¾©Î¦ÛµMÀô¹Ò·½ÀY·P¬V¤HÃþ¡C©Ò¦³¤½§G¤Fªº¤HÃþ·P¬V¡A¥]¬A³Ìªñ¨Ó¦Û¤g¦Õ¨äªº¡A¦ü¥G¬O¥Ñ®a¸V¤ºªº¯f¬rÂX¼W¤Î»P®a¸Vºò±K±µÄ²¦Ó¨ú±o¡C²{®É¦b³¾Ãþ³¡¤À¬y¦æªº°Êª«¤HÃþ°ª­P¯f©Ê¸V¬y·PH5N1¯f¬r¡A¨ä½ÆÂø©Ê¤Î¼ç¦bªº¼vÅT¡A»Ý­n¬ì¾Ç®a¡B¬Fªv®a¤Î¤½²³¶¡¹w¥ý°Óij¤ÎÂÔ·Vªº¦æ°Ê¡C

 

 

¸ê®Æ

  • Allan WH, Alexander DJ, Pomeroy BS, Parsons G. Use of virulence index tests for avian influenza viruses. Avian Dis 1977; 21: 359-63. Abstract: http://amedeo.com/lit.php?id=907578

  • Amonsin A, Payungporn S, Theamboonlers A, et al. Genetic characterization of H5N1 influenza A viruses isolated from zoo tigers in Thailand. Virology 2005; Sep 26; [Epub ahead of print] Abstract: http://amedeo.com/lit.php?id=16194557

  • Banks J, Speidel ES, Moore E, Plowright L, Piccirillo A, Capua I, Cordioli P, fioretti A, Alexander DJ. Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy. Arch Virol. 2001;146: 963-73. Abstract: http://amedeo.com/lit.php?id=11448033

  • Bano S, Naeem K, Malik SA. Evaluation of pathogenic potential of avian influenzavirus serotype H9N2 in chicken. Avian Dis 2003; 47: Suppl: 817-22. Abstract: http://amedeo.com/lit.php?id=14575070

  • Beard CW, Schnitzlein WM, Tripathy DN. Protection of chicken against highly pathogenic avian influenzavirus (H5N2) by recombinant fowlpox viruses. Avian Dis 1991; 35: 356-9. Abstract: http://amedeo.com/lit.php?id=1649592

  • Beck JR, Swayne DE, Davison S, Casavant S, Gutierrez C. Validation of egg yolk antibody testing as a method to determine influenza status in white leghorn hens. Avian Dis 2003; 47: Suppl: 1196-9. Abstract: http://amedeo.com/lit.php?id=14575141

  • Belshe RB. The origins of pandemic influenza--lessons from the 1918 virus. N Engl J Med. 2005; 353: 2209-11.

  • Brown IH, Harris PA, McCauley JW, Alexander DJ. Multiple genetic reassortment of avian and human influenza A viruses in european pigs, resulting in the emergence of an H1N2 virus of novel genotype. J Gen Virol 1998; 79: 2947-2955. Abstract: http://amedeo.com/lit.php?id=9880008

  • Brown IH, Hill ML, Harris PA, Alexander DJ, McCauley JW. Genetic characterisation of an influenza A virus of unusual subtype (H1N7) isolated from pigs in England. Arch Virol 1997; 142: 1045-50. Abstract: http://amedeo.com/lit.php?id=9191869

  • Bulaga LL, Garber L, Senne DA, et al. Epidemiologic and surveillance studies on avian influenza in live-bird markets in New York and New Jersey, 2001. Avian Dis 2003; 47: Suppl: 996-1001. Abstract: http://amedeo.com/lit.php?id=14575100

  • Butt KM, Smith GJ, Chen H, Zhang LJ, Leung YH, Xu KM, Lim W, Webster RG, Yuen KY, Peiris JS, Guan Y. Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J Clin Microbiol. 2005 Nov;43(11):5760-7. Abstract: http://amedeo.com/lit.php?id=16272514

  • Capua I, Mutinelli F. Low pathogenicity (LPAI) and highly pathogenic (HPAI) avian influenza in turkeys and chicken. In: Capua I, Mutinelli F. (eds.), A Colour Atlas and Text on Avian Influenza, Papi Editore, Bologna, 2001, pp. 13-20

  • Capua I, Mutinelli F, Marangon S, Alexander DJ. H7N1 avian influenza in Italy (1999-2000) in intensively reared chicken and turkeys. Av Pathol 2000; 29: 537-43

  • Cattoli G, Terregino C, Brasola V, Rodriguez JF, Capua I. Development and preliminary validation of an ad hoc N1-N3 discriminatory test for the control of avian influenza in Italy. Avian Dis 2003; 47: Suppl: 1060-2. Abstract: http://amedeo.com/lit.php?id=14575111

  • Cattoli G, Drago A, Maniero S, Toffan A, Bertoli E, Fassina S, Terregino C, Robbi C, Vicenzoni G, Capua I. Comparison of three rapid detection systems for type A influenza virus on tracheal swabs of experimentally and naturally infected birds. Avian Pathol 2004; 33: 432-7. Abstract: http://amedeo.com/lit.php?id=15370041

  • Cauthen AN, Swayne DE, Schultz-Cherry S, Perdue ML, Suarez DL. Continued circulation in China of highly pathogenic avian influenza viruses encoding the hemagglutinin gene associated with the 1997 H5N1 outbreak in poultry and humans. J Virol 2000; 74: 6592-9. Abstract: http://amedeo.com/lit.php?id=10864673 - Full text http://jvi.asm.org/cgi/content/full/74/14/6592

  • Centanni E, Savonuzzi O, cited by Stubbs E.L.: "Fowl plague." Diseases of Poultry. 4th ed.; 1965.

  • Chen J, Lee KH, Steinhauer DA, Stevens DJ, Skehel JJ, Wiley DC. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell 1998; 95: 409-17. Abstract: http://amedeo.com/lit.php?id=9814710

  • Chen H, Smith GJ, Zhang SY, Qin K, Wang J, Li KS, Webster RG, Peiris JS, Guan Y. Avian flu: H5N1 virus outbreak in migratory waterfowl. Nature 2005; 436: 191-2. Abstract: http://amedeo.com/lit.php?id=16007072

  • Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, Gordon S, Guan Y, Peiris JS. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002; 360: 1831-7. Abstract: http://amedeo.com/lit.php?id=12480361

  • Choi YK, Nguyen TD, Ozaki H, Webby RJ, Puthavathana P, Buranathal C, Chaisingh A, Auewarakul P, Hanh NT, Ma SK, Hui PY, Guan Y, Peiris JS, Webster RG. Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Viet Nam and Thailand in 2004. J Virol 2005; 79: 10821-5 16051873

  • Claas EC, Osterhaus AD, van Beek R, et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998; 351: 472-7. Abstract: http://amedeo.com/lit.php?id=9482438

  • Collins RA, Ko LS, So KL, Ellis T, Lau LT, Yu AC. Detection of highly pathogenic and low pathogenic avian influenza subtype H5 (EurAsian lineage) using NASBA. J Virol Methods 2002; 103: 213-25. Abstract: http://amedeo.com/lit.php?id=12008015

  • Crawford J, Wilkinson B, Vosnesensky A, et al. Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. Vaccine 1999; 17: 2265-74. Abstract: http://amedeo.com/lit.php?id=10403594

  • Davison S, Ziegler AF, Eckroade RJ. Comparison of an antigen-capture enzyme immunoassay with virus isolation for avian influenza from flied samples. Avian Dis. 1998; 42: 791-5. Abstract: http://amedeo.com/lit.php?id=9876850

  • Du Ry van Beest Holle M, Meijer A, Koopmans M, de Jager C. Human-to-human transmission of avian influenza A/H7N7, The Netherlands, 2003. Euro Surveill 2005; 10 [Epub ahead of print]. Abstract: http://amedeo.com/lit.php?id=16371696

  • Dybkaer K, Munch M, Handberg KJ, Jorgensen PH. Application and evaluation of RT-PCR-ELISA for the nucleoprotein and RT-PCR for detection of low-pathogenic H5 and H7 subtypes of avian influenza virus. J Vet Diagn Invest 2004; 16: 51-6. Abstract: http://amedeo.com/lit.php?id=14974847

  • Elbers AR, Kamps B, Koch G. Performance of gross lesions at postmortem for the detection of outbreaks during the avian influenza A virus (H7N7) epidemic in The Netherlands in 2003. Avian Pathol 2004; 33: 418-22. Abstract: http://amedeo.com/lit.php?id=15370039

  • Elbers AR, Koch G, Bouma A. Performance of clinical signs in poultry for the detection of outbreaks during the avian influenza A (H7N7) epidemic in The Netherlands in 2003. Avian Pathol 2005; 34: 181-7. Abstract: http://amedeo.com/lit.php?id=16191700

  • Fouchier RA, Bestebroer TM, Herfst S, Van Der Kemp L, Rimmelzwaan GF, Osterhaus AD. Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene. J Clin Microbiol 2000; 38: 4096-101. Abstract: http://amedeo.com/lit.php?id=11060074

  • Fouchier RA, Olsen B, Bestebroer TM, et al. Influenza A virus surveillance in wild birds in Northern Europe in 1999 and 2000. Avian Dis 2003; 47: Suppl: 857-60. Abstract: http://amedeo.com/lit.php?id=14575077

  • Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, Kuiken T, Rimmelzwaan GF, Schutten M, Van Doornum GJ, Koch G, Bosman A, Koopmans M, Osterhaus AD. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A 2004; 101: 1356-61. Abstract: http://amedeo.com/lit.php?id=14745020 - Full text at http://www.pnas.org/cgi/content/full/101/5/1356

  • Fouchier RA, Munster V, Wallensten A, et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 2005; 79: 2814-22. Abstract: http://amedeo.com/lit.php?id=15709000

  • Gabriel G, Dauber B, Wolff T, Planz O, Klenk HD, Stech J. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci U S A 2005; 102: 18590-5. Abstract: http://amedeo.com/lit.php?id=16339318

  • Gambaryan AS, Tuzikov AB, Pazynina GV, Webster RG, Matrosovich MN, Bovin NV. H5N1 chicken influenza viruses display a high binding affinity for Neu5Acalpha2-3Galbeta1-4(6-HSO3)GlcNAc-containing receptors. Virology. 2004; 326: 310-6.

  • Gambaryan A, Yamnikova S, Lvov D, et al. Receptor specificity of influenza viruses from birds and mammals: new data on involvement of the inner fragments of the carbohydrate chain. Virology 2005; 334: 276-83. Abstract: http://amedeo.com/lit.php?id=15780877

  • Gambaryan A, Tuzikov A, Pazynina G, Bovin N, Balish A, Klimov A. Evolution of the receptor binding phenotype of influenza A (H5) viruses. Virology 2006; 344: 432-8. Abstract: http://amedeo.com/lit.php?id=16226289

  • Garcia M, Crawford JM, Latimer JW, Rivera-Cruz E, Perdue ML. Heterogeneity in the hemagglutinin gene and emergence of the highly pathogenic phenotype among recent H5N2 avian influenza viruses from Mexico. J Gen Virol 1996; 77: 1493-504. Abstract: http://amedeo.com/lit.php?id=8757992

  • Garcia A, Johnson H, Srivastava DK, Jayawardene DA, Wehr DR, Webster RG. Efficacy of inactivated H5N2 influenza vaccines against lethal A/Chicken/Queretaro/19/95 infection. Avian Dis 1998; 42: 248-56. Abstract: http://amedeo.com/lit.php?id=9645315

  • Giannecchini S, Campitelli L, Calzoletti L, De Marco MA, Azzi A, Donatelli I. Comparison of in vitro replication features of H7N3 influenza viruses from wild ducks and turkeys: potential implications for interspecies transmission. J Gen Virol 2006; 87: 171-5. Abstract: http://amedeo.com/lit.php?id=16361429

  • Gorman OT, Bean WJ, Webster RG. Evolutionary processes in influenza viruses: divergence, rapid evolution, and stasis. Curr Top Microbiol Immunol 1992; 176: 75-97. Abstract: http://amedeo.com/lit.php?id=1600756

  • Govorkova EA, Rehg JE, Krauss S, Yen HL, Guan Y, Peiris M, Nguyen TM, Hanh TH, Puthavathana P, Long HT, Buranathai C, Lim W, Webster RG, Hoffmann E. Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J Virol 2005; 79: 2191-2198. Abstract: http://amedeo.com/lit.php?id=15681421

  • Guan Y, Peiris JS, Poon LL, et al. Reassortants of H5N1 influenza viruses recently isolated from aquatic poultry in Hong Kong SAR. Avian Dis 2003; 47: Suppl: 911-3. Abstract: http://amedeo.com/lit.php?id=14575085

  • Guan Y, Peiris M, Kong KF, et al. H5N1 influenza viruses isolated from geese in Southeastern China: evidence for genetic reassortment and interspecies transmission to ducks. Virology 2002b; 292: 16-23. Abstract: http://amedeo.com/lit.php?id=11878904

  • Guo Y, Wang M, Kawaoka Y, Gorman O, Ito T, Saito T, Webster RG. Characterization of a new avian-like influenza A virus from horses in China. Virology 1992; 188: 245-55. Abstract: http://amedeo.com/lit.php?id=1314452

  • Haque ME, Koppaka V, Axelsen PH, Lentz BR. Properties and Structures of the Influenza and HIV Fusion Peptides on Lipid Membranes: Implications for a Role in Fusion. Biophys J. 2005; 89:3183-94. Abstract: http://amedeo.com/lit.php?id=16183890

  • Hatta M, Gao P, Halfmann P, Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. 2001; Science 293: 1840-1842. Abstract: http://amedeo.com/lit.php?id=11546875

  • Hayden F, Croisier A. Transmission of avian influenza viruses to and between humans. J Infect Dis 2005;192: 1311-4.

  • Henzler DJ, Kradel DC, Davison S, et al. Epidemiology, production losses, and control measures associated with an outbreak of avian influenza subtype H7N2 in Pennsylvania (1996-98). Avian Dis 2003; 47: Suppl: 1022-36. Abstract: http://amedeo.com/lit.php?id=14575105

  • Herrler G, Hausmann J, Klenk HD. Sialic acid as receptor determinant of ortho- and paramyxoviruses. In: Rosenberg A (ed), Biology of the Sialic Acids, Plenum Press NY, 1995: p. 315-336

  • Horimoto T, Kawaoka Y. Molecular changes in virulent mutants arising from avirulent avian influenza viruses during replication in 14-day-old embryonated eggs. Virology 1995; 206: 755-9. Abstract: http://amedeo.com/lit.php?id=7831837

  • Hulse-Post DJ, Sturm-Ramirez KM, Humberd J, et al. Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci U S A 2005; 102: 10682-7. Abstract: http://amedeo.com/lit.php?id=16030144

  • Ito T, Kawaoka Y, Nomura A, Otsuki K. Receptor specificity of influenza A viruses from sea mammals correlates with lung sialyloligosaccharides in these animals. J Vet Med Sci 1999; 61: 955-8. Abstract: http://amedeo.com/lit.php?id=10487239

  • Ito T, Okazaki K, Kawaoka Y, Takada A, Webster RG, Kida H (1995). Perpetuation of influenza A viruses in Alaskan waterfowl reservoirs. Arch.Virol. 140, 1163-1172. Abstract: http://amedeo.com/lit.php?id=7646350

  • Jin M, Wang G, Zhang R, Zhao S, Li H, Tan Y, Chen H. Development of enzyme-linked immunosorbent assay with nucleoprotein as antigen for detection of antibodies to avian influenza virus. Avian Dis 2004; 48: 870-8. Abstract: http://amedeo.com/lit.php?id=15666868

  • Jones YL, Swayne DE. Comparative pathobiology of low and high pathogenicity H7N3 Chilean avian influenza viruses in chicken. Avian Dis 2004; 48: 119-28. Abstract: http://amedeo.com/lit.php?id=15077805

  • Karasin AI, Brown IH, Carman S, Olsen CW. Isolation and characterization of H4N6 avian influenza viruses from pigs with pneumonia in Canada. J Virol 2000; 74: 9322-7. Abstract: http://amedeo.com/lit.php?id=10982381

  • Kawaoka Y, Naeve CW, Webster RG. Is virulence of H5N2 influenza viruses in chicken associated with loss of carbohydrate from the hemagglutinin? Virology 1984; 139: 303-16. Abstract: http://amedeo.com/lit.php?id=6516214

  • Kessler N, Ferraris O, Palmer K, Marsh W, Steel A. Use of the DNA flow-thru chip, a three-dimensional biochip, for typing and subtyping of influenza viruses. J Clin Microbiol. 2004; 42: 2173-85. Abstract: http://amedeo.com/lit.php?id=15131186

  • Kim JA, Ryu SY, Seo SH. Cells in the respiratory and intestinal tracts of chicken have different proportions of both human and avian influenza virus receptors. J Microbiol 2005; 43: 366-9. Abstract: http://amedeo.com/lit.php?id=16145552

  • Klempner MS, Shapiro DS. Crossing the species barrier - one small step to man, one giant leap to mankind. N Engl J Med 2004; 350: 1171-2. Epub 2004 Feb 25. http://amedeo.com/lit.php?id=14985471

  • Klopfleisch R, Werner O, Mundt E, Harder T, Teifke JP. Neurotropism of highly pathogenic avian influenzavirus A/chicken/Indonesia/2003 (H5N1) in experimentally infected pigeons (Columbia livia f. domestica). Vet Pathol 2006; in press

  • Koopmans M, Wilbrink B, Conyn M, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 2004; 363: 587-93. Abstract: http://amedeo.com/lit.php?id=14987882

  • Krauss S, Walker D, Pryor SP, Niles L, Chenghong L, Hinshaw VS, Webster RG. Influenza A viruses of migrating wild aquatic birds in North America. Vector Borne Zoonotic Dis 2004; 4: 177-89. Abstract: http://amedeo.com/lit.php?id=15631061

  • Kwon YK, Joh SJ, Kim MC, Sung HW, Lee YJ, Choi JG, Lee EK, Kim JH. Highly pathogenic avian influenza (H5N1) in the commercial domestic ducks of South Korea. Avian Pathol 2005; 34: 367-70. Abstract: http://amedeo.com/lit.php?id=16147575

  • Landman WJ, Schrier CC. Avian influenza: eradication from commercial poultry is still not in sight. Tijdschr. Diergeneeskd 2004; 129: 782-96. Abstract: http://amedeo.com/lit.php?id=15624878

  • Lee CW, Suarez DL. Application of real-time RT-PCR for the quantitation and competitive replication study of H5 and H7 subtype avian influenza virus. J Virol Methods. 2004; 119: 151-8. Abstract: http://amedeo.com/lit.php?id=15158597

  • Lee CW, Swayne DE, Linares JA, Senne DA, Suarez DL. H5N2 avian influenza outbreak in Texas in 2004: the first highly pathogenic strain in the United States in 20 years? J Virol 2005; 79: 11412-21. Abstract: http://amedeo.com/lit.php?id=16103192

  • Lee CW, Senne DA, Suarez DL. Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza. Vaccine 2004; 22: 3175-81. Abstract: http://amedeo.com/lit.php?id=15297071

  • Li J, Chen S, Evans DH. Typing and subtyping influenza virus using DNA microarrays and multiplex reverse transcriptase PCR. J Clin Microbiol. 2001; 39: 696-704. Abstract: http://amedeo.com/lit.php?id=11158130

  • Li KS, Guan Y, Wang J, et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 2004; 430: 209-13. Abstract: http://amedeo.com/lit.php?id=15241415

  • Li C, Yu K, Tian G, Yu D, Liu L, Jing B, Ping J, Chen H. Evolution of H9N2 influenza viruses from domestic poultry in Mainland China. Virology 2005b; 340: 70-83. Abstract: http://amedeo.com/lit.php?id=16026813

  • Li Z, Chen H, Jiao P, Deng G, Tian G, Li Y, Hoffmann E, Webster RG, Matsuoka Y, Yu K . Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. 2005a; J Virol 79; 12058-12064. Abstract: http://amedeo.com/lit.php?id=16140781

  • Liu M, Wood JM, Ellis T, Krauss S, Seiler P, Johnson C, Hoffmann E, Humberd J, Hulse D, Zhang Y, Webster RG, Perez DR. Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics. Virology. 2003; 314: 580-90. Abstract: http://amedeo.com/lit.php?id=14554086

  • Lu H, Castro AE, Pennick K, Liu J, Yang Q, Dunn P, Weinstock D, Henzler D. Survival of avian influenza virus H7N2 in SPF chickens and their environments. Avian Dis. 2003; 47: 1015-21. Abstract: http://amedeo.com/lit.php?id=14575104

  • Luschow D, Werner O, Mettenleiter TC, Fuchs W. Vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene. Vaccine. 2001 Jul 20;19(30):4249-59. http://amedeo.com/lit.php?id=11457552

  • Maines TR, Lu XH, Erb SM, et al. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol 2005; 79: 11788-800. Abstract: http://amedeo.com/lit.php?id=16140756

  • Mannelli A, Ferre N, Marangon S. Analysis of the 1999-2000 highly pathogenic avian influenza (H7N1) epidemic in the main poultry-production area in northern Italy. Prev Vet Med. 2005 Oct 19; [Epub ahead of print]. Abstract: http://amedeo.com/lit.php?id=16243405

  • Marangon S, Capua I, Pozza G, Santucci U. Field experiences in the control of avian influenza outbreaks in densely populated poultry areas. Dev Biol (Basel) 2004; 119: 155-64. Abstract: http://amedeo.com/lit.php?id=15742627

  • Marangon S, Capua I. Control of AI in Italy: from "Stamping-out"-strategy to emergency and prophylactic vaccination. In: Proc. Internat. Conf on Avian Influenza Paris 2005; O.I.E., p. 29.

  • Matrosovich MN, Krauss S, Webster RG. H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity. Virology 2001; 281: 156-62. Abstract: http://amedeo.com/lit.php?id=11277689

  • Meulemans G, Carlier MC, Gonze M, Petit P. Comparison of hemagglutination-inhibition, agar gel precipitin, and enzyme-linked immunosorbent assay for measuring antibodies against influenza viruses in chicken. Avian Dis 1987; 31: 560-3. Abstract: http://amedeo.com/lit.php?id=2960313

  • Mo IP, Brugh M, fletcher OJ, Rowland GN, Swayne DE. Comparative pathology of chicken experimentally inoculated with avian influenza viruses of low and high pathogenicity. Avian Dis 1997; 41: 125-36. Abstract: http://amedeo.com/lit.php?id=9087329

  • Mutinelli F, Capua I, Terregino C, Cattoli G. Clinical, gross, and microscopic findings in different avian species naturally infected during the H7N1 low- and high-pathogenicity avian influenza epidemics in Italy during 1999 and 2000. Avian Dis 2003a; 47: Suppl: 844-8. Abstract: http://amedeo.com/lit.php?id=14575075

  • Mutinelli F, Hablovarid H, Capua I. Avian embryo susceptibility to Italian H7N1 avian influenza viruses belonging to different lineages. Avian Dis 2003b; 47: Suppl: 1145-9. Abstract: http://amedeo.com/lit.php?id=14575131

  • Nakatani H, Nakamura K, Yamamoto Y, Yamada M, Yamamoto Y. Epidemiology, pathology, and immunohistochemistry of layer hens naturally affected with H5N1 highly pathogenic avian influenza in Japan. Avian Dis 2005; 49: 436-41. Abstract: http://amedeo.com/lit.php?id=16252503

  • Neumann G, Brownlee GG, Fodor E, Kawaoka Y. Orthomyxovirus replication, transcription, and polyadenylation. Curr Top Microbiol Immunol 2004; 283: 121-43. Abstract: http://amedeo.com/lit.php?id=15298169

  • Nestorowicz A, Kawaoka Y, Bean WJ, Webster RG. Molecular analysis of the hemagglutinin genes of Australian H7N7 influenza viruses: role of passerine birds in maintenance or transmission? Virology 1987; 160: 411-8. Abstract: http://amedeo.com/lit.php?id=3660587

  • Okazaki K, Takada A, Ito T, et al. Precursor genes of future pandemic influenza viruses are perpetuated in ducks nesting in Siberia. Arch Virol 2000; 145: 885-93. Abstract: http://amedeo.com/lit.php?id=10881676

  • Pasick J, Handel K, Robinson J, et al. Intersegmental recombination between the hemagglutinin and matrix genes was responsible for the emergence of a highly pathogenic H7N3 avian influenza virus in British Columbia. J Gen Virol 2005; 86: 727-31. Abstract: http://amedeo.com/lit.php?id=15722533

  • Payungporn S, Phakdeewirot P, Chutinimitkul S, Theamboonlers A, Keawcharoen J, Oraveerakul K, Amonsin A, Poovorawan Y. Single-step multiplex reverse transcription-polymerase chain reaction (RT-PCR) for influenza A virus subtype H5N1 detection. Viral Immunol 2004; 17: 588-93. Abstract: http://amedeo.com/lit.php?id=15671756

  • Perdue ML, Garcia M, Senne D, Fraire M. Virulence-associated sequence duplication at the hemagglutinin cleavage site of avian influenza viruses. Virus Res 1997; 49: 173-86. Abstract: http://amedeo.com/lit.php?id=9213392

  • Perdue ML, Suarez DL. Structural features of the avian influenza virus hemagglutinin that influence virulence. Vet Microbiol 2000; 74: 77-86. Abstract: http://amedeo.com/lit.php?id=10799780

  • Perkins LE, Swayne DE. Pathogenicity of a Hong Kong-origin H5N1 highly pathogenic avian influenza virus for emus, geese, ducks, and pigeons. Avian Dis 2002a; 46: 53-63. Abstract: http://amedeo.com/lit.php?id=11924603

  • Perkins LE, Swayne DE. Susceptibility of laughing gulls (Larus atricilla) to H5N1 and H5N3 highly pathogenic avian influenza viruses. Avian Dis 2002b; 46: 877-85. Abstract: http://amedeo.com/lit.php?id=12495048

  • Perkins LE, Swayne DE. Comparative susceptibility of selected avian and mammalian species to a Hong Kong-origin H5N1 high-pathogenicity avian influenza virus. Avian Dis. 2003;47(3 Suppl):956-67. Abstract: http://amedeo.com/lit.php?id=14575094

  • Perroncito CE. [it. Typhoid epizootic in gallinaceous birds.] Epizoozia tifoide nei gallinacei. Torino: Annali Accademia Agricoltura 1878; 21:87-126.

  • Phipps LP, Essen SC, Brown IH. Genetic subtyping of influenza A viruses using RT-PCR with a single set of primers based on conserved sequences within the HA2 coding region. J Virol Methods 2004;122:119-22. Abstract: http://amedeo.com/lit.php?id=15488629

  • Rohm C, Horimoto T, Kawaoka Y, Suss J, Webster RG. Do hemagglutinin genes of highly pathogenic avian influenza viruses constitute unique phylogenetic lineages? Virology 1995; 209: 664-70. Abstract: http://amedeo.com/lit.php?id=7778300

  • Rott R, Orlich M, Scholtissek C. Correlation of pathogenicity and gene constellation of influenza A viruses. III. Non-pathogenic recombinants derived from highly pathogenic parent strains. J Gen Virol 1979; 44: 471-7. Abstract: http://amedeo.com/lit.php?id=521799

  • Rott R, Klenk HD, Nagai Y, Tashiro M. Influenza viruses, cell enzymes, and pathogenicity. Am J Respir Crit Care Med. 1995; 152: S16-9. Abstract: http://amedeo.com/lit.php?id=7551406

  • Rust MJ, Lakadamyali M, Zhang F, Zhuang X. Assembly of endocytic machinery around individual influenza viruses during viral entry. Nat Struct Mol Biol 2004; 11: 567-73. Abstract: http://amedeo.com/lit.php?id=15122347

  • Sala G, Cordioli P, Moreno-Martin A, et al. ELISA test for the detection of influenza H7 antibodies in avian sera. Avian Dis 2003; 47: Suppl: 1057-9. Abstract: http://amedeo.com/lit.php?id=14575110

  • Schäfer W. Vergleichende sero-immunologische Untersuchungen über die Viren der Influenza und klassischen Geflügelpest. Zeitschr Naturforschung 1955; 10b: 81-91

  • Scholtissek C, Hinshaw VS, Olsen CW. Influenza in pigs and their role as the intermediate host. In: Nicholson KG, Webster RG, Hay AJ (eds.), Textbook of Influenza, Blackwell Scientific, Oxford, 1998; p 137-145

  • Selleck PW, Lowther SL, Russell GM, Hooper PT. Rapid diagnosis of highly pathogenic avian influenza using pancreatic impression smears. Avian Dis 2003; 47 (3 Suppl): 1190-5. Abstract: http://amedeo.com/lit.php?id=14575140

  • Senne DA, Panigrahy B, Kawaoka Y, et al. Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. Avian Dis 1996; 40: 425-37. Abstract: http://amedeo.com/lit.php?id=8790895

  • Seo SH, Hoffmann E, Webster RG. The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses. Virus Res 2004; 103: 107-13. Abstract: http://amedeo.com/lit.php?id=15163498

  • Shafer AL, Katz JB, Eernisse KA. Development and validation of a competitive enzyme-linked immunosorbent assay for detection of type A influenza antibodies in avian sera. Avian Dis. 1998; 42: 28-34. Abstract: http://amedeo.com/lit.php?id=9533078

  • Shinya K, Hamm S, Hatta M, Ito H, Ito T, Kawaoka Y. PB2 amino acid at position 627 affects replicative efficency but not cell tropism of Hong Kong H5N1 influenza viruses in mice. Virology 2004; 320: 258-266. Abstract: http://amedeo.com/lit.php?id=15016548

  • Shortridge KF, Zhou NN, Guan Y, et al. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology. 1998 Dec 20;252(2):331-42. Abstract: http://amedeo.com/lit.php?id=9878612

  • Smith AW, Skilling DE, Castello JD, Rogers SO. Ice as a reservoir for pathogenic human viruses: specifically, caliciviruses, influenza viruses, and enteroviruses. Med Hypotheses 2004; 63: 560-6. Abstract: http://amedeo.com/lit.php?id=15324997

  • Snyder DB, Marquardt WW, Yancey FS, Savage PK. An enzyme-linked immunosorbent assay for the detection of antibody against avian influenza virus. Avian Dis 1985; 29: 136-44. Abstract: http://amedeo.com/lit.php?id=3985870

  • Spackman E, Senne DA, Myers TJ, et al. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol 2002; 40: 3256-60. Abstract: http://amedeo.com/lit.php?id=12202562

  • Stallknecht DE, Kearney MT, Shane SM, Zwank PJ. Effects of pH, temperature, and salinity on persistence of avian influenza viruses in water. Avian Dis 1990b; 34: 412-8. Abstract: http://amedeo.com/lit.php?id=2142421

  • Stech J, Garn H, Wegmann M, Wagner R, Klenk HD. A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin. 2005; Nat Med 11: 683-689. Abstract: http://amedeo.com/lit.php?id=15924146

  • Suzuki Y. Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol Pharm Bull 2005; 28: 399-408. Abstract: http://amedeo.com/lit.php?id=15744059

  • Swayne DE, Beck JR, Kinney N. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chicken preimmunized with a fowl pox vaccine. Avian Dis 2000b; 44: 132-7. Abstract: http://amedeo.com/lit.php?id=10737653

  • Swayne DE, Beck JR, Mickle TR. Efficacy of recombinant fowl poxvirus vaccine in protecting chicken against a highly pathogenic Mexican-origin H5N2 avian influenza virus. Avian Dis 1997; 41: 910-22. Abstract: http://amedeo.com/lit.php?id=9454926

  • Swayne DE, Beck JR, Perdue ML, Beard CW. Efficacy of vaccines in chicken against highly pathogenic Hong Kong H5N1 avian influenza. Avian Dis 2001; 45: 355-65. Abstract: http://amedeo.com/lit.php?id=11417815

  • Swayne DE, Garcia M, Beck JR, Kinney N, Suarez DL. Protection against diverse highly pathogenic H5 avian influenza viruses in chicken immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 2000c; 18: 1088-95. Abstract: http://amedeo.com/lit.php?id=10590330

  • Swayne DE, Suarez DL, Schultz-Cherry S, et al. Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chicken against influenza and Newcastle disease. Avian Dis 2003; 47: Suppl: 1047-50. Abstract: http://amedeo.com/lit.php?id=14575108

  • Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, Fanning TG. Characterization of the 1918 influenza virus polymerase genes. Nature. 2005 Oct 6;437(7060):889-93. Abstract: http://amedeo.com/lit.php?id=16208372

  • Tian G, Zhang S, Li Y, Bu Z, Liu P, Zhou J, Li C, Shi J, Yu K, Chen H. Protective efficacy in chicken, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics. Virology 2005; 341: 153-62. Abstract: http://amedeo.com/lit.php?id=16084554

  • Tumpey TM, Alvarez R, Swayne DE, Suarez DL. Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the nonstructural protein of influenza A virus. J Clin Microbiol 2005; 43: 676-83. Abstract: http://amedeo.com/lit.php?id=15695663

  • Veits J, Luschow D, Kindermann K, et al. Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chicken, and UL0 mutants expressing influenza virus hemagglutinin (H7) protect against ILT and fowl plague. J Gen Virol 2003; 84: 3343-52. Abstract: http://amedeo.com/lit.php?id=14645915

  • Wagner R, Matrosovich M, Klenk HD. Functional balance between haemagglutinin and neuraminidase in influenzavirus infections. Rev Med Virol 2002; 12: 159-66. Abstract: http://amedeo.com/lit.php?id=11987141

  • Walker JA, Kawaoka Y. Importance of conserved amino acids at the cleavage site of the haemagglutinin of a virulent avian influenza A virus. J Gen Virol 1993; 74: 311-4. Abstract: http://amedeo.com/lit.php?id=8429306

  • Wan H, Perez DR. Quail carry sialic acid receptors compatible with binding of avian and human influenza viruses. Virology. 2005 Dec 1; [Epub ahead of print]. Abstract: http://amedeo.com/lit.php?id=16325879

  • Watowich SJ, Skehel JJ, Wiley DC. Crystal structures of influenza virus hemagglutinin in complex with high-affinity receptor analogs. Structure 1994; 2: 719-31. Abstract: http://amedeo.com/lit.php?id=7994572

  • Webster RG, Yakhno MA, Hinshaw VS, Bean WJ, Murti KG. Intestinal influenza: replication and characterization of influenza viruses in ducks. Virology 1978; 84: 268-78. Abstract: http://amedeo.com/lit.php?id=23604

  • Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992; 56: 152-79. Abstract: http://amedeo.com/lit.php?id=1579108

  • Whittaker G, Bui M, Helenius A. The role of nuclear import and export in influenza virus infection. Trends Cell Biol. 1996 Feb;6(2):67-71. Abstract: http://amedeo.com/lit.php?id=15157497

  • Wood GW, McCauley JW, Bashiruddin JB, Alexander DJ. Deduced amino acid sequences at the haemagglutinin cleavage site of avian influenza A viruses of H5 and H7 subtypes. Arch Virol 1993; 130: 209-17. Abstract: http://amedeo.com/lit.php?id=8503786

  • Woolcock PR, McFarland MD, Lai S, Chin RP. Enhanced recovery of avian influenza virus isolates by a combination of chicken embryo inoculation methods. Avian Dis 2001; 45: 1030-5. Abstract: http://amedeo.com/lit.php?id=11785874

  • Xu X, Subbarao, Cox NJ, Guo Y. Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology 1999; 261: 15-9. Abstract: http://amedeo.com/lit.php?id=10484749

  • Xu C, Fan W, Wei R, Zhao H (2004). Isolation and identification of swine influenza recombinant A/Swine/Shandong/1/2003 (H9N2) virus. Microbes Infect 6: 919-25. Abstract: http://amedeo.com/lit.php?id=15310468

  • Yuen KY, Chan PK, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351: 467-71. Abstract: http://amedeo.com/lit.php?id=9482437

  • Zhou N, He S, Zhang T, Zou W, Shu L, Sharp GB, Webster RG. Influenza infection in humans and pigs in southeastern China. Arch Virol. 1996;141(3-4):649-61. Abstract: http://amedeo.com/lit.php?id=8645101

  • Zhou EM, Chan M, Heckert RA, Riva J, Cantin MF. Evaluation of a competitive ELISA for detection of antibodies against avian influenza virus nucleoprotein. Avian Dis 1998; 42: 517-22. Abstract: http://amedeo.com/lit.php?id=9777152

 

 

Department of Biochemistry, The Chinese University of Hong Kong © 2006